<!DOCTYPE html> <html lang = "en">
 <body>

<h2>Pubmed_ID: 32908149</h2>

<h3>A distinct lineage of Caudovirales that encodes a deeply branching multi-subunit RNA polymerase</h3>

<h3>Caudovirales的独特谱系，其编码深分支的多亚基RNA聚合酶</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41467-020-18281-3</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32908149/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature communications  {'ISSN': '2041-1723', 'Name': 'nature communications', '2015': '11.329', '2016': '12.124', '2017': '12.353', '2018': '11.878', '2019': '12.121'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Bacteriophages play critical roles in the biosphere, but their vast genomic diversity has obscured their evolutionary origins, and phylogenetic analyses have traditionally been hindered by their lack of universal phylogenetic marker genes. In this study we mine metagenomic data and identify a clade of Caudovirales that encodes the β and β' subunits of multi-subunit RNA polymerase (RNAP), a high-resolution phylogenetic marker which enables detailed evolutionary analyses. Our RNAP phylogeny revealed that the Caudovirales RNAP forms a clade distinct from cellular homologs, suggesting an ancient acquisition of this enzyme. Within these multimeric RNAP-encoding Caudovirales (mReC), we find that the similarity of major capsid proteins and terminase large subunits further suggests they form a distinct clade with common evolutionary origin. Our study characterizes a clade of RNAP-encoding Caudovirales and suggests the ancient origin of this enzyme in this group, underscoring the important role of viruses in the early evolution of life on Earth.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 噬菌体在生物圈中起着至关重要的作用，但是它们巨大的基因组多样性掩盖了它们的进化起源，并且传统上由于缺乏通用的系统发生标记基因而阻碍了系统发育分析。在这项研究中，我们挖掘了宏基因组学数据，并鉴定了一段Caudovirales，它编码多亚基RNA聚合酶（RNAP）的β和β'亚基，高分辨率的系统发育标记物可以进行详细的进化分析。我们的RNAP系统发育研究表明，伪狂犬病RNAP形成了与细胞同源物不同的进化枝，这表明该酶已在古代获得。在这些多聚体RNAP编码伪病毒（mReC）中，我们发现主要衣壳蛋白和末端酶大亚基的相似性进一步表明它们形成了具有共同进化起源的独特进化枝。我们的研究表征了RNA编码Caudovirales的进化枝，并暗示了该酶在这一族群中的古老起源，强调了病毒在地球生命早期发展中的重要作用。</p>

<h2>Pubmed_ID: 32907933</h2>

<h3>Circulation of gut-preactivated naïve CD8 + T cells enhances antitumor immunity in B cell-defective mice</h3>

<h3>肠道预激活的幼稚CD8 + T细胞的循环增强了B细胞缺陷小鼠的抗肿瘤免疫力</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1073/pnas.2010981117</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32907933/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Proceedings of the National Academy of Sciences of the United States of America  {'ISSN': '0027-8424', 'Name': 'proceedings of the national academy of sciences of the united states of america', '2015': '9.423', '2016': '9.661', '2017': '9.504', '2018': '9.58', '2019': '9.412'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiome has garnered attention as an effective target to boost immunity and improve cancer immunotherapy. We found that B cell-defective (BCD) mice, such as µ-membrane targeted deletion (µMT) and activation-induced cytidine deaminase (AID) knockouts (KOs), have elevated antitumor immunity under specific pathogen-free but not germ-free conditions. Microbial dysbiosis in these BCD mice enriched the type I IFN (IFN) signature in mucosal CD8+ T cells, resulting in up-regulation of the type I IFN-inducible protein stem cell antigen-1 (Sca-1). Among CD8+ T cells, naïve cells predominantly circulate from the gut to the periphery, and those that had migrated from the mesenteric lymph nodes (mLNs) to the periphery had significantly higher expression of Sca-1. The gut-educated Sca-1+ naïve subset is endowed with enhanced mitochondrial activity and antitumor effector potential. The heterogeneity and functional versatility of the systemic naïve CD8+ T cell compartment was revealed by single-cell analysis and functional assays of CD8+ T cell subpopulations. These results indicate one of the potential mechanisms through which microbial dysbiosis regulates antitumor immunity.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道微生物组已作为提高免疫力和改善癌症免疫疗法的有效靶点而受到关注。我们发现B细胞缺陷（BCD）小鼠，例如µ膜靶向缺失（µMT）和激活诱导的胞苷脱氨酶（AID）敲除（KOs），在无特定病原体但非无菌的条件下具有较高的抗肿瘤免疫力条件。这些BCD小鼠中的微生物异养病丰富了粘膜CD8+T细胞中的I型IFN（IFN）信号，导致I型IFN诱导型蛋白干细胞抗原1（Sca-1）上调。在CD8+T细胞中，幼稚细胞主要从肠道循环到外周，而那些从肠系膜淋巴结（mLNs）迁移到外周的细胞则具有较高的Sca-1表达。肠道培养的Sca-1+幼稚子集具有增强的线粒体活性和抗肿瘤效应子的潜力。通过CD8+T细胞亚群的单细胞分析和功能分析，揭示了系统性幼稚CD8+T细胞区室的异质性和功能多样性。这些结果表明微生物营养不良调节抗肿瘤免疫力的潜在机制之一。</p>

<h2>Pubmed_ID: 32907634</h2>

<h3>Impact of industrial production system parameters on chicken microbiomes: mechanisms to improve performance and reduce Campylobacter</h3>

<h3>工业生产系统参数对鸡微生物群的影响：提高性能和减少弯曲杆菌的机制</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1186/s40168-020-00908-8</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32907634/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Microbiome  {'ISSN': '2049-2618', 'Name': 'microbiome', '2015': '9', '2016': '9.133', '2017': '9.133', '2018': '10.465', '2019': '11.607'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: The factors affecting host-pathogen ecology in terms of the microbiome remain poorly studied. Chickens are a key source of protein with gut health heavily dependent on the complex microbiome which has key roles in nutrient assimilation and vitamin and amino acid biosynthesis. The chicken gut microbiome may be influenced by extrinsic production system parameters such as Placement Birds/m2 (stocking density), feed type and additives. Such parameters, in addition to on-farm biosecurity may influence performance and also pathogenic bacterial numbers such as Campylobacter. In this study, three different production systems 'Normal' (N), 'Higher Welfare' (HW) and 'Omega-3 Higher Welfare' (O) were investigated in an industrial farm environment at day 7 and day 30 with a range of extrinsic parameters correlating performance with microbial dynamics and Campylobacter presence. Results: Our data identified production system N as significantly dissimilar from production systems HW and O when comparing the prevalence of genera. An increase in Placement Birds/m2 density led to a decrease in environmental pressure influencing the microbial community structure. Prevalence of genera, such as Eisenbergiella within HW and O, and likewise Alistipes within N were representative. These genera have roles directly relating to energy metabolism, amino acid, nucleotide and short chain fatty acid (SCFA) utilisation. Thus, an association exists between consistent and differentiating parameters of the production systems that affect feed utilisation, leading to competitive exclusion of genera based on competition for nutrients and other factors. Campylobacter was identified within specific production system and presence was linked with the increased diversity and increased environmental pressure on microbial community structure. Addition of Omega-3 though did alter prevalence of specific genera, in our analysis did not differentiate itself from HW production system. However, Omega-3 was linked with a positive impact on weight gain. Conclusions: Overall, our results show that microbial communities in different industrial production systems are deterministic in elucidating the underlying biological confounders, and these recommendations are transferable to farm practices and diet manipulation leading to improved performance and better intervention strategies against Campylobacter within the food chain. Video Abstract.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：就微生物组而言，影响宿主-病原体生态的因素仍然研究不足。鸡是肠道健康的重要蛋白质来源，在很大程度上取决于复杂的微生物组，而微生物组在营养同化以及维生素和氨基酸的生物合成中具有关键作用。鸡肠道微生物组可能会受到外部生产系统参数的影响，例如放置禽鸟/m2（放养密度），饲料类型和添加剂。这样的参数，除了农场上的生物安全性外，还可能影响生产性能，并影响诸如弯曲杆菌的致病细菌数量。在这项研究中，在第7天和第30天的工业农场环境中，研究了三种不同的生产系统“正常”（N），“较高福利”（HW）和“Omega-3较高福利”（O）。外在参数将性能与微生物动力学和弯曲杆菌的存在相关联。结果：比较属的患病率时，我们的数据确定生产系统N与生产系统HW和O显着不同。安置鸟类/平方米密度的增加导致影响微生物群落结构的环境压力降低。属的流行，例如HW和O内的艾森伯格氏菌，以及N内的阿利斯皮虫同样具有代表性。这些属的作用与能量代谢，氨基酸，核苷酸和短链脂肪酸（SCFA）的利用直接相关。因此，在影响饲料利用的生产系统的一致和差异化参数之间存在关联，导致基于对养分和其他因素的竞争而对属进行竞争性排斥。在特定的生产系统中鉴定出弯曲杆菌，其存在与微生物群落结构多样性的增加和环境压力的增加有关。虽然添加Omega-3确实改变了特定属的流行，但在我们的分析中并未将其与硬件生产系统区分开。但是，Omega-3对体重增加有积极影响。结论：总的来说，我们的结果表明，不同工业生产系统中的微生物群落在阐明潜在的生物混杂因素方面具有确定性，并且这些建议可用于农场实践和饮食操作，从而改善了对食物链内弯曲杆菌的性能和更好的干预策略。录像摘要。</p>

<h2>Pubmed_ID: 32907632</h2>

<h3>Nanoparticle treatment of maize analyzed through the metatranscriptome: compromised nitrogen cycling, possible phytopathogen selection, and plant hormesis</h3>

<h3>通过转录组分析玉米的纳米粒子处理：氮循环受损，可能的植物病原体选择和植物兴奋作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1186/s40168-020-00904-y</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32907632/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Microbiome  {'ISSN': '2049-2618', 'Name': 'microbiome', '2015': '9', '2016': '9.133', '2017': '9.133', '2018': '10.465', '2019': '11.607'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: The beneficial use of nanoparticle silver or nanosilver may be confounded when its potent antimicrobial properties impact non-target members of natural microbiomes such as those present in soil or the plant rhizosphere. Agricultural soils are a likely sink for nanosilver due to its presence in agrochemicals and land-applied biosolids, but a complete assessment of nanosilver's effects on this environment is lacking because the impact on the natural soil microbiome is not known. In a study assessing the use of nanosilver for phytopathogen control with maize, we analyzed the metatranscriptome of the maize rhizosphere and observed multiple unintended effects of exposure to 100 mg kg-1 nanosilver in soil during a growth period of 117 days. Results: We found several unintended effects of nanosilver which could interfere with agricultural systems in the long term. Firstly, the archaea community was negatively impacted with a more than 30% decrease in relative abundance, and as such, their involvement in nitrogen cycling and specifically, nitrification, was compromised. Secondly, certain potentially phytopathogenic fungal groups showed significantly increased abundances, possibly due to the negative effects of nanosilver on bacteria exerting natural biocontrol against these fungi as indicated by negative interactions in a network analysis. Up to 5-fold increases in relative abundance have been observed for certain possibly phytopathogenic fungal genera. Lastly, nanosilver exposure also caused a direct physiological impact on maize as illustrated by increased transcript abundance of aquaporin and phytohormone genes, overall resulting in a stress level with the potential to yield hormetically stimulated plant root growth. Conclusions: This study indicates the occurrence of significant unintended effects of nanosilver use on corn, which could turn out to be negative to crop productivity and ecosystem health in the long term. We therefore highlight the need to include the microbiome when assessing the risk associated with nano-enabled agriculture. Video Abstract.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：当纳米银或纳米银的有效抗菌特性影响天然微生物群的非目标成员（例如土壤或植物根际中存在的那些）时，可能会混淆有益的使用。由于农业土壤中存在农用化学品和土地施用的生物固体，因此农业土壤很可能是纳米银的沉陷物，但是由于对自然土壤微生物组的影响尚不清楚，因此尚缺乏对纳米银对这种环境的影响的完整评估。在一项评估使用纳米银防治玉米植物病原体的研究中，我们分析了玉米根际的转录组，并观察到在117天的生长期暴露于土壤中的100mgkg-1纳米银会产生多种意想不到的影响。结果：我们发现了纳米银的一些意想不到的影响，它们可能长期干扰农业系统。首先，古细菌群落受到不利影响，相对丰度降低了30％以上，因此，它们参与氮循环，特别是硝化的能力受到损害。其次，某些潜在的植物致病真菌基团显示出大量增加的数量，这可能是由于纳米银对细菌的负面影响，如对细菌的自然生物控制，如网络分析中的负面相互作用所示。对于某些可能具有植物病原性的真菌属，已经观察到相对丰度提高了5倍。最后，纳米银的暴露也对玉米造成了直接的生理影响，如水通道蛋白和植物激素基因的转录丰度增加所表明的那样，总体上导致了胁迫水平，并可能产生受刺激的植物根部生长。结论：这项研究表明，纳米银的使用会对玉米产生重大的意想不到的影响，从长远来看，这可能对作物生产力和生态系统健康产生负面影响。因此，在评估与纳米农业相关的风险时，我们强调需要包括微生物组。录像摘要。</p>

<h2>Pubmed_ID: 32901029</h2>

<h3>Enhancing mucosal immunity by transient microbiota depletion</h3>

<h3>通过短暂的微生物群落耗竭增强粘膜免疫</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41467-020-18248-4</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32901029/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature communications  {'ISSN': '2041-1723', 'Name': 'nature communications', '2015': '11.329', '2016': '12.124', '2017': '12.353', '2018': '11.878', '2019': '12.121'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Tissue resident memory CD8+ T cells (Trm) are poised for immediate reactivation at sites of pathogen entry and provide optimal protection of mucosal surfaces. The intestinal tract represents a portal of entry for many infectious agents; however, to date specific strategies to enhance Trm responses at this site are lacking. Here, we present TMDI (Transient Microbiota Depletion-boosted Immunization), an approach that leverages antibiotic treatment to temporarily restrain microbiota-mediated colonization resistance, and favor intestinal expansion to high densities of an orally-delivered Listeria monocytogenes strain carrying an antigen of choice. By augmenting the local chemotactic gradient as well as the antigenic load, this procedure generates a highly expanded pool of functional, antigen-specific intestinal Trm, ultimately enhancing protection against infectious re-challenge in mice. We propose that TMDI is a useful model to dissect the requirements for optimal Trm responses in the intestine, and also a potential platform to devise novel mucosal vaccination approaches.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 组织常驻记忆CD8+T细胞（Trm）可以在病原体进入部位立即重新激活，并为粘膜表面提供最佳保护。肠道代表了许多传染源的进入门户。但是，到目前为止，缺乏在该站点上增强Trm响应的特定策略。在这里，我们介绍了TMDI（瞬时微生物群耗竭增强免疫），该方法利用抗生素治疗来暂时抑制微生物群介导的定殖抗性，并有利于肠道扩张至高密度的口服递送的携带选择抗原的李斯特菌单核细胞增生李斯特菌。通过增加局部趋化梯度以及抗原负荷，该程序产生了功能性的，抗原特异性的肠Trm的高度扩展的库，最终增强了对小鼠感染性再攻击的保护。我们认为，TMDI是剖析肠道中最佳Trm反应要求的有用模型，也是设计新颖的粘膜疫苗接种方法的潜在平台。</p>

<h2>Pubmed_ID: 32901017</h2>

<h3>Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity</h3>

<h3>肠道菌群来源的短链脂肪酸对免疫细胞IL-22产生和肠道免疫的调节</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41467-020-18262-6</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32901017/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature communications  {'ISSN': '2041-1723', 'Name': 'nature communications', '2015': '11.329', '2016': '12.124', '2017': '12.353', '2018': '11.878', '2019': '12.121'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Innate lymphoid cells (ILCs) and CD4+ T cells produce IL-22, which is critical for intestinal immunity. The microbiota is central to IL-22 production in the intestines; however, the factors that regulate IL-22 production by CD4+ T cells and ILCs are not clear. Here, we show that microbiota-derived short-chain fatty acids (SCFAs) promote IL-22 production by CD4+ T cells and ILCs through G-protein receptor 41 (GPR41) and inhibiting histone deacetylase (HDAC). SCFAs upregulate IL-22 production by promoting aryl hydrocarbon receptor (AhR) and hypoxia-inducible factor 1α (HIF1α) expression, which are differentially regulated by mTOR and Stat3. HIF1α binds directly to the Il22 promoter, and SCFAs increase HIF1α binding to the Il22 promoter through histone modification. SCFA supplementation enhances IL-22 production, which protects intestines from inflammation. SCFAs promote human CD4+ T cell IL-22 production. These findings establish the roles of SCFAs in inducing IL-22 production in CD4+ T cells and ILCs to maintain intestinal homeostasis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 先天性淋巴样细胞（ILC）和CD4+T细胞产生IL-22，这对于肠道免疫至关重要。微生物群是肠道中IL-22产生的关键。但是，尚不清楚调节CD4+T细胞和ILC产生IL-22的因素。在这里，我们显示微生物群衍生的短链脂肪酸（SCFA）促进CD4+T细胞和ILC通过G蛋白受体41（GPR41）分泌IL-22，并抑制组蛋白脱乙酰基酶（HDAC）。SCFA通过促进芳烃受体（AhR）和缺氧诱导因子1α（HIF1α）表达来上调IL-22的产生，而后者受mTOR和Stat3差异调节。HIF1α直接与Il22启动子结合，而SCFA通过组蛋白修饰增加HIF1α与Il22启动子的结合。补充SCFA可以增强IL-22的产生，从而保护肠道免受炎症。SCFA促进人CD4+T细胞IL-22的产生。这些发现确立了SCFA在诱导CD4+T细胞和ILC中IL-22产生以维持肠道稳态中的作用。</p>

<h2>Pubmed_ID: 32900998</h2>

<h3>Integration of molecular profiles in a longitudinal wellness profiling cohort</h3>

<h3>在纵向健康状况分析队列中整合分子特征</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41467-020-18148-7</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32900998/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Nature communications  {'ISSN': '2041-1723', 'Name': 'nature communications', '2015': '11.329', '2016': '12.124', '2017': '12.353', '2018': '11.878', '2019': '12.121'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: An important aspect of precision medicine is to probe the stability in molecular profiles among healthy individuals over time. Here, we sample a longitudinal wellness cohort with 100 healthy individuals and analyze blood molecular profiles including proteomics, transcriptomics, lipidomics, metabolomics, autoantibodies and immune cell profiling, complemented with gut microbiota composition and routine clinical chemistry. Overall, our results show high variation between individuals across different molecular readouts, while the intra-individual baseline variation is low. The analyses show that each individual has a unique and stable plasma protein profile throughout the study period and that many individuals also show distinct profiles with regards to the other omics datasets, with strong underlying connections between the blood proteome and the clinical chemistry parameters. In conclusion, the results support an individual-based definition of health and show that comprehensive omics profiling in a longitudinal manner is a path forward for precision medicine.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 精密医学的一个重要方面是研究健康个体随时间变化的分子谱稳定性。在这里，我们对100名健康个体的纵向健康队列进行了采样，并分析了血液分子概况，包括蛋白质组学，转录组学，脂质组学，代谢组学，自身抗体和免疫细胞谱，并补充了肠道菌群组成和常规临床化学。总体而言，我们的结果表明，不同分子读数之间的个体间差异很大，而个体内部的基线差异却很小。分析表明，每个个体在整个研究期间均具有独特且稳定的血浆蛋白谱，并且许多个体在其他蛋白质组学数据集方面也表现出独特的谱，血液蛋白质组学与临床化学参数之间具有很强的潜在联系。总之，结果支持基于个人的健康定义，并表明以纵向方式进行全面的组学分析是精密医学的发展之路。</p>

<h2>Pubmed_ID: 32900801</h2>

<h3>How the Anaerobic Enteropathogen Clostridioides difficile Tolerates Low O 2 Tensions</h3>

<h3>艰难梭菌厌氧梭状芽孢杆菌如何耐受低O 2张力</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1128/mBio.01559-20</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32900801/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: mBio  {'ISSN': '2150-7511', 'Name': 'mbio', '2015': '6.975', '2016': '6.956', '2017': '6.689', '2018': '6.747', '2019': '6.784'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Clostridioides difficile is a major cause of diarrhea associated with antibiotherapy. After germination of C. difficile spores in the small intestine, vegetative cells are exposed to low oxygen (O2) tensions. While considered strictly anaerobic, C. difficile is able to grow in nonstrict anaerobic conditions (1 to 3% O2) and tolerates brief air exposure indicating that this bacterium harbors an arsenal of proteins involved in O2 detoxification and/or protection. Tolerance of C. difficile to low O2 tensions requires the presence of the alternative sigma factor, σB, involved in the general stress response. Among the genes positively controlled by σB, four encode proteins likely involved in O2 detoxification: two flavodiiron proteins (FdpA and FdpF) and two reverse rubrerythrins (revRbr1 and revRbr2). As previously observed for FdpF, we showed that both purified revRbr1 and revRbr2 harbor NADH-linked O2- and H2O2-reductase activities in vitro, while purified FdpA mainly acts as an O2-reductase. The growth of a fdpA mutant is affected at 0.4% O2, while inactivation of both revRbrs leads to a growth defect above 0.1% O2 O2-reductase activities of these different proteins are additive since the quadruple mutant displays a stronger phenotype when exposed to low O2 tensions compared to the triple mutants. Our results demonstrate a key role for revRbrs, FdpF, and FdpA proteins in the ability of C. difficile to grow in the presence of physiological O2 tensions such as those encountered in the colon.IMPORTANCE Although the gastrointestinal tract is regarded as mainly anoxic, low O2 tension is present in the gut and tends to increase following antibiotic-induced disruption of the host microbiota. Two decreasing O2 gradients are observed, a longitudinal one from the small to the large intestine and a second one from the intestinal epithelium toward the colon lumen. Thus, O2 concentration fluctuations within the gastrointestinal tract are a challenge for anaerobic bacteria such as C. difficile This enteropathogen has developed efficient strategies to detoxify O2 In this work, we identified reverse rubrerythrins and flavodiiron proteins as key actors for O2 tolerance in C. difficile These enzymes are responsible for the reduction of O2 protecting C. difficile vegetative cells from associated damages. Original and complex detoxification pathways involving O2-reductases are crucial in the ability of C. difficile to tolerate O2 and survive to O2 concentrations encountered in the gastrointestinal tract.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 艰难梭菌是与抗生物疗法有关的腹泻的主要原因。在小肠中的艰难梭菌孢子萌发后，植物细胞暴露于低氧（O2）张力下。尽管艰难梭菌被认为是严格厌氧的，但它能够在非严格的厌氧条件下生长（1-3％的O2），并能承受短暂的空气暴露，这表明该细菌具有与O2解毒和/或保护有关的蛋白质库。艰难梭菌对低O2张力的耐受性要求存在替代sigma因子σB，该因子参与一般的应力响应。在受σB阳性控制的基因中，四种编码可能与O2排毒有关的蛋白：两种黄素二铁蛋白（FdpA和FdpF）和两种反向红荧素（revRbr1和revRbr2）。如以前对FdpF的观察，我们显示纯化的revRbr1和revRbr2均在体外具有NADH连接的O2-和H2O2-还原酶活性，而纯化的FdpA主要充当O2还原酶。fdpA突变体的生长在0.4％的O2下受到影响，而两个revRbrs的失活均导致生长缺陷超过0.1％O2的O2还原酶活性，这些不同蛋白质的活性是可加的，因为四倍体突变体在暴露于低O2时表现出更强的表型与三重突变体相比紧张。我们的研究结果表明，revRbrs，FdpF和FdpA蛋白在艰难梭菌在生理O2紧张（例如在结肠中遇到的O2）存在下生长的能力中起着关键作用。尽管胃肠道被认为主要是缺氧的，但低O2张力存在于肠道中，并在抗生素诱导的宿主微生物群破坏后趋于增加。观察到两个减小的O2梯度，从小肠到大肠的纵向O2梯度，从肠上皮向结肠腔的第二个O2梯度。因此，胃肠道中的O2浓度波动对厌氧菌（如艰难梭菌）是一种挑战。这种病原菌已开发出有效的方法来对O2进行解毒。在这项工作中，我们确定了逆向红荧素和黄酮二铁蛋白是艰难梭菌对O2耐受的关键因素这些酶负责减少保护艰难梭菌营养细胞免受相关损害的氧气。涉及O2还原酶的原始和复杂的解毒途径对于艰难梭菌耐受O2并存活至胃肠道中遇到的O2浓度至关重要。</p>

<h2>Pubmed_ID: 32900799</h2>

<h3>Prebiotics and Community Composition Influence Gas Production of the Human Gut Microbiota</h3>

<h3>益生元和群落组成影响人类肠道菌群的产气量</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1128/mBio.00217-20</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32900799/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: mBio  {'ISSN': '2150-7511', 'Name': 'mbio', '2015': '6.975', '2016': '6.956', '2017': '6.689', '2018': '6.747', '2019': '6.784'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Prebiotics confer benefits to human health, often by promoting the growth of gut bacteria that produce metabolites valuable to the human body, such as short-chain fatty acids (SCFAs). While prebiotic selection has strongly focused on maximizing the production of SCFAs, less attention has been paid to gases, a by-product of SCFA production that also has physiological effects on the human body. Here, we investigate how the content and volume of gas production by human gut microbiota are affected by the chemical composition of the prebiotic and the community composition of the microbiota. We first constructed a linear system model based on mass and electron balance and compared the theoretical product ranges of two prebiotics, inulin and pectin. Modeling shows that pectin is more restricted in product space, with less potential for H2 but more potential for CO2 production. An ex vivo experimental system showed pectin degradation produced significantly less H2 than inulin, but CO2 production fell outside the theoretical product range, suggesting fermentation of fecal debris. Microbial community composition also impacted results: methane production was dependent on the presence of Methanobacteria, while interindividual differences in H2 production during inulin degradation were driven by a Lachnospiraceae taxon. Overall, these results suggest that both the chemistry of the prebiotic and the composition of the microbiota are relevant to gas production. Metabolic processes that are relatively prevalent in the microbiome, such as H2 production, will depend more on substrate, while rare metabolisms such as methanogenesis depend more strongly on microbiome composition.IMPORTANCE Prebiotic fermentation in the gut often leads to the coproduction of short-chain fatty acids (SCFAs) and gases. While excess gas production can be a potential problem for those with functional gut disorders, gas production is rarely considered during prebiotic design. In this study, we combined the use of theoretical models and an ex vivo experimental platform to illustrate that both the chemical composition of the prebiotic and the community composition of the human gut microbiota can affect the volume and content of gas production during prebiotic fermentation. Specifically, more prevalent metabolic processes such as hydrogen production were strongly affected by the oxidation state of the probiotic, while rare metabolisms such as methane production were less affected by the chemical nature of the substrate and entirely dependent on the presence of Methanobacteria in the microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 益生元通常通过促进肠道细菌的生长来赋予人体健康，肠道细菌会产生对人体有价值的代谢产物，例如短链脂肪酸（SCFA）。虽然益生元的选择一直集中在最大化SCFA的产生上，但对气体的关注却很少，气体是SCFA产生的副产物，对人体也有生理作用。在这里，我们调查了益生元的化学成分和微生物群落组成如何影响人类肠道微生物产生的气体的含量和体积。我们首先基于质量和电子平衡构建了线性系统模型，然后比较了两种益生元菊粉和果胶的理论产品范围。模型表明，果胶在产品空间上的限制更大，H2的潜力较小，但CO2的生产潜力更大。体外实验系统显示果胶降解产生的H2明显少于菊粉，但CO2的产生超出理论产品范围，表明粪便碎片发酵。微生物群落组成也会影响结果：甲烷的产生取决于甲烷菌的存在，而菊粉降解过程中菊粉降解过程中H2产生的个体间差异则由Lachnospiraceae类群驱动。总体而言，这些结果表明，益生元的化学性质和微生物群的组成均与产气有关。在微生物组中相对普遍的代谢过程（例如H2的产生）将更多地依赖于底物，而罕见的新陈代谢（例如甲烷生成）则更强烈地依赖于微生物组的组成。重要事项肠道中的益生元发酵通常会导致短链脂肪的联产酸（SCFA）和气体。尽管对于患有功能性肠病的人来说，过量的产气可能是一个潜在的问题，但是在益生元设计期间很少考虑产气。在这项研究中，我们结合了理论模型和离体实验平台的使用，以说明益生元的化学组成和人类肠道菌群的群落组成都可以影响益生元发酵过程中产气的量和含量。具体而言，益生菌的氧化状态强烈影响更普遍的代谢过程（例如产氢），而罕见的代谢（例如甲烷生产）受底物的化学性质影响较小，并且完全取决于微生物群中甲烷菌的存在。</p>

<h2>Pubmed_ID: 32900255</h2>

<h3>How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process</h3>

<h3>口服益生菌如何影响进行性多发性硬化症实验模型的严重性？将共生细菌带入神经变性过程</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1813532</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32900255/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: A growing number of studies support that the bidirectional interactions between the gut microbiota, the immune system and the CNS are relevant for the pathophysiology of MS. Several studies have reported alterations in the gut microbiome of MS patients. In addition, a variety of studies in animal models of MS have suggested that specific members of the gut commensal microbiota can exacerbate or ameliorate neuroinflammation. Probiotics represent oral nontoxic immunomodulatory agents that would exert benefits when using in combination with current MS therapy. Here we investigate the effect of Vivomixx on the gut microbiome and central and peripheral immune responses in a murine model of primary progressive MS. Vivomixx administration was associated with increased abundance of many taxa such as Bacteroidetes, Actinobacteria, Tenericutes and TM7. This was accompanied by a clear improvement of the motor disability of Theiler's virus infected mice; in the CNS Vivomixx reduced microgliosis, astrogliosis and leukocyte infiltration. Notably, the presence of Breg cells (CD19+CD5+CD1dhigh) in the CNS was enhanced by Vivomixx, and while spinal cord gene expression of IL-1β and IL-6 was diminished, the probiotic promoted IL-10 gene expression. One of the most significant findings was the increased plasma levels of butyrate and acetate levels in TMEV-mice that received Vivomixx. Peripheral immunological changes were subtle but interestingly, the probiotic restricted IL-17 production by Th17-polarized CD4+ T-cells purified from the mesenteric lymph nodes of Theiler's virus infected mice. Our data reinforce the beneficial effects of oral probiotics that would be coadjuvant treatments to current MS therapies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的研究支持肠道微生物群，免疫系统和CNS之间的双向相互作用与MS的病理生理有关。几项研究报道了MS患者肠道微生物组的改变。此外，在多发性硬化症动物模型中的各种研究表明，肠道共生微生物群的特定成员可以加剧或减轻神经炎症。益生菌代表口服无毒免疫调节剂，当与当前的MS治疗结合使用时，将发挥有益作用。在这里，我们研究了原发进行性MS小鼠模型中Vivomixx对肠道微生物组以及中枢和外周免疫应答的影响。Vivomixx的施用与许多类群如拟杆菌，放线菌，Tenericutes和TM7的丰度增加有关。这伴随着泰勒病毒感染小鼠的运动障碍的明显改善。在中枢神经系统体内，Vivomixx减少了小胶质细胞减少，星形胶质细胞减少和白细胞浸润。值得注意的是，Vivomixx增强了CNS中Breg细胞（CD19+CD5+CD1dhigh）的存在，并且虽然减少了IL-1β和IL-6的脊髓基因表达，但益生菌促进了IL-10基因表达。最重要的发现之一是接受Vivomixx的TMEV小鼠血浆丁酸和乙酸盐水平升高。外周免疫学变化微妙，但有趣的是，益生菌限制了从泰勒病毒感染小鼠的肠系膜淋巴结中纯化的Th17极化CD4+T细胞产生的IL-17。我们的数据加强了口服益生菌的有益效果，这将是目前MS治疗的辅助治疗方法。</p>

<h2>Pubmed_ID: 32897773</h2>

<h3>Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance</h3>

<h3>年轻微生物菌群与老年微生物菌群向无菌小鼠的移植：增加短链脂肪酸并改善认知能力</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1814107</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32897773/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Aging is associated with cognitive decline and decreased concentrations of short-chain fatty acids (SCFAs) in the gut. SCFAs are significant in that they are protective to the gut and other organs. We tested the hypothesis that the aged gut microbiome alone is sufficient to decrease SCFAs in the host and produces cognitive decline. Fecal transplant gavages (FTGs) from aged (18-20 months) or young (2-3 months) male C57BL/6 mice into germ-free male C57BL/6 mice (N = 11 per group) were initiated at ~3 months of age. Fecal samples were collected and behavioral testing was performed over the study period. Bacterial community structures and relative abundances were measured in fecal samples by sequencing the bacterial 16S ribosomal RNA gene. Mice with aged and young microbiomes showed clear differences in bacterial β diversity at 30, 60, and 90 d (P = .001 for each) after FTGs. The fecal SCFAs, acetate, propionate, and butyrate (microbiome effect, P < .01 for each) were decreased in mice with an aged microbiome. Mice with an aged microbiome demonstrated depressive-like behavior, impaired short-term memory, and impaired spatial memory over the 3 months following the initial FTG as assessed by the tail suspension (P = .008), the novel object recognition (P < .001), and the Barnes Maze (P = .030) tests, respectively. We conclude that an aged microbiome alone is sufficient to decrease SCFAs in the host and to produce cognitive decline.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 衰老与认知能力下降和肠道中短链脂肪酸（SCFA）浓度降低有关。SCFA具有重要意义，因为它们对肠道和其他器官具有保护作用。我们测试了这样的假设，即单独的老年肠道微生物组足以降低宿主中的SCFA并产生认知能力下降。在大约3个月的时间开始从年龄（18-20个月）或年轻（2-3个月）的雄性C57BL/6小鼠到无菌的雄性C57BL/6小鼠（每组N=11）进行粪便移植管饲（FTG）。年龄。在研究期间收集粪便样品并进行行为测试。通过对细菌16S核糖体RNA基因测序，测量粪便样品中的细菌群落结构和相对丰度。FTG后30、60和90d，具有老年和年轻微生物群的小鼠表现出明显的细菌β多样性差异（每个P均=0.001）。在具有高龄微生物组的小鼠中，粪便中的SCFA，乙酸盐，丙酸盐和丁酸盐（微生物组效应，每种P<0.01）均降低。微生物衰老的小鼠在最初的FTG后3个月内表现出抑郁样行为，短期记忆受损和空间记忆受损（通过尾部悬架评估（P=.008），即新物体识别（P<。001）和巴恩斯迷宫（P=.030）测试。我们得出的结论是，仅老年微生物组就足以降低宿主中的SCFA并产生认知能力下降。</p>

<h2>Pubmed_ID: 32895494</h2>

<h3>Microbial interactions in the mosquito gut determine Serratia colonization and blood-feeding propensity</h3>

<h3>蚊子中的微生物相互作用决定了沙雷氏菌的定殖和采血倾向</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-00763-3</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32895494/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/07/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: How microbe-microbe interactions dictate microbial complexity in the mosquito gut is unclear. Previously we found that, Serratia, a gut symbiont that alters vector competence and is being considered for vector control, poorly colonized Aedes aegypti yet was abundant in Culex quinquefasciatus reared under identical conditions. To investigate the incompatibility between Serratia and Ae. aegypti, we characterized two distinct strains of Serratia marcescens from Cx. quinquefasciatus and examined their ability to infect Ae. aegypti. Both Serratia strains poorly infected Ae. aegypti, but when microbiome homeostasis was disrupted, the prevalence and titers of Serratia were similar to the infection in its native host. Examination of multiple genetically diverse Ae. aegypti lines found microbial interference to S. marcescens was commonplace, however, one line of Ae. aegypti was susceptible to infection. Microbiome analysis of resistant and susceptible lines indicated an inverse correlation between Enterobacteriaceae bacteria and Serratia, and experimental co-infections in a gnotobiotic system recapitulated the interference phenotype. Furthermore, we observed an effect on host behavior; Serratia exposure to Ae. aegypti disrupted their feeding behavior, and this phenotype was also reliant on interactions with their native microbiota. Our work highlights the complexity of host-microbe interactions and provides evidence that microbial interactions influence mosquito behavior.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 微生物与微生物之间的相互作用如何决定蚊帐中的微生物复杂性还不清楚。先前我们发现，沙雷氏菌是改变载体能力的肠道共生体，目前正被考虑用于载体控制，其定殖的埃及伊蚊不易定植，但在相同条件下饲养的库克斯库克斯库蚊中含量很高。调查沙雷氏菌和Ae之间的不相容性。aegypti，我们表征了来自Cx的两种粘质沙雷氏菌。quinquefasciatus并检查其感染Ae的能力。埃及。两种沙雷氏菌菌株对Ae的感染均较差。埃及，但是当微生物组稳态被破坏时，沙雷氏菌的患病率和滴度与本地宿主的感染相似。检查多种遗传多样的Ae。埃及线发现微生物对Marcescens的干扰很普遍，但是其中一条是ae。埃及容易感染。耐药和易感株系的微生物组分析表明，肠杆菌科细菌和沙雷氏菌之间呈负相关，并且在gnotobiotic系统中进行的实验性共感染概括了干扰表型。此外，我们观察到对宿主行为的影响。沙雷菌暴露于Ae。埃及伊蚊破坏了它们的摄食行为，这种表型也依赖于与其天然微生物群的相互作用。我们的工作突出了宿主-微生物相互作用的复杂性，并提供了证据表明微生物相互作用会影响蚊子的行为。</p>

<h2>Pubmed_ID: 32893721</h2>

<h3>Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites</h3>

<h3>了解粪便微生物菌群移植治疗复发性艰难梭菌及其他困难的功效机制：肠道微生物衍生的代谢产物的贡献</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1810531</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893721/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Fecal microbiota transplant (FMT) is a highly-effective therapy for recurrent Clostridioides difficile infection (rCDI), and shows promise for certain non-CDI indications. However, at present, its mechanisms of efficacy have remained poorly understood. Recent studies by our laboratory have noted the particular key importance of restoration of gut microbe-metabolite interactions in the ability of FMT to treat rCDI, including the impact of FMT upon short chain fatty acid (SCFAs) and bile acid metabolism. This includes a significant impact of these metabolites upon the life cycle of C. difficile directly, along with potential postulated additional benefits, including effects upon host immune response. In this Addendum, we first present an overview of these recent advancements in this field, and then describe additional novel data from our laboratory on the impact of FMT for rCDI upon several gut microbial-derived metabolites which had not previously been implicated as being of relevance.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 粪便微生物菌群移植（FMT）是复发性艰难梭菌感染（rCDI）的高效疗法，对某些非CDI适应症显示出希望。然而，目前，其功效机制仍知之甚少。我们实验室最近的研究表明，肠道微生物与代谢物之间的相互作用恢复对FMT治疗rCDI的能力具有特别重要的意义，包括FMT对短链脂肪酸（SCFA）和胆汁酸代谢的影响。这包括这些代谢物直接对艰难梭菌的生命周期产生重大影响，以及潜在的可能的其他好处，包括对宿主免疫反应的影响。在本附录中，我们首先概述了该领域的最新进展，然后描述了来自我们实验室的关于FMT对rCDI对几种肠道微生物衍生代谢产物的影响的新数据。。</p>

<h2>Pubmed_ID: 32893715</h2>

<h3>Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening</h3>

<h3>强化化疗对急性髓细胞性白血病肠道屏障和微生物群的影响和后果：粘膜强化作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1800897</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893715/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal barrier of patients with AML and in wild-type mice. Next, we assessed the potential benefit of strengthening the mucosal barrier in transgenic mice releasing a recombinant protein able to reinforce the mucus layer (Tg222). In patients, we observed a decrease of plasma citrulline, which is a marker of the functional enterocyte mass, of short-chain fatty acids and of fecal bacterial load, except for Escherichia coli and Enterococcus spp., which became dominant. Both the α and β-diversities of fecal microbiota decreased. In wild-type mice, citrulline levels decreased under chemotherapy along with an increase of E. coli and Enterococcus spp load associated with concomitant histologic impairment. By comparison with wild-type mice, Tg222 mice, 3 days after completing chemotherapy, had higher citrulline levels, a faster healing epithelium, and preserved α-diversity of their intestinal microbiota. This was associated with reduced bacterial translocations. Our results highlight the intestinal damage and the dysbiosis induced by the 7 + 3 regimen. As a proof of concept, our transgenic model suggests that strengthening the intestinal barrier is a promising approach to limit BSI and improve AML patients' outcome.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 诱导化疗（7+3方案）仍然是急性髓细胞性白血病（AML）患者的金标准，但会导致肠道受损，导致多种并发症，例如血流感染（BSI）。我们旨在研究诱导化疗对AML患者和野生型小鼠肠屏障的影响。接下来，我们评估了在转基因小鼠中释放能够增强粘液层（Tg222）的重组蛋白中增强粘膜屏障的潜在益处。在患者中，我们观察到血浆瓜氨酸的减少，而瓜氨酸是功能性肠上皮细胞质量，短链脂肪酸和粪便细菌负荷的标志物，但大肠杆菌和肠球菌属除外，这些占主导地位。粪便微生物群的α和β多样性均降低。在野生型小鼠中，瓜氨酸水平在化学疗法下下降，同时伴随组织学损害的大肠杆菌和肠球菌载量增加。与野生型小鼠相比，Tg222小鼠在完成化疗后3天具有较高的瓜氨酸水平，较快的上皮愈合，并保留了肠道菌群的α多样性。这与减少细菌易位有关。我们的结果强调了7+3方案引起的肠损伤和营养不良。作为概念的证明，我们的转基因模型表明，加强肠屏障是限制BSI和改善AML患者预后的有前途的方法。</p>

<h2>Pubmed_ID: 32893709</h2>

<h3>Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota</h3>

<h3>代谢物分析揭示了几丁质-葡聚糖与肠道菌群的相互作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1810530</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893709/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dietary fibers are considered beneficial nutrients for health. Current data suggest that their interaction with the gut microbiota largely contributes to their physiological effects. In this context, chitin-glucan (CG) improves metabolic disorders associated with obesity in mice, but its effect on gut microbiota has never been evaluated in humans. This study explores the effect of a 3-week intervention with CG supplementation in healthy individuals on gut microbiota composition and bacterial metabolites. CG was given to healthy volunteers (n = 15) for three weeks as a supplement (4.5 g/day). Food diary, visual analog and Bristol stool form scales and a "quality of life" survey were analyzed. Among gut microbiota-derived metabolites, bile acids (BA), long- and short-chain fatty acids (LCFA, SCFA) profiling were assessed in stool samples. The gut microbiota (primary outcome) was analyzed by Illumina sequencing. A 3-week supplementation with CG is well tolerated in healthy humans. CG induces specific changes in the gut microbiota composition, with Eubacterium, Dorea and Roseburia genera showing the strongest regulation. In addition, CG increased bacterial metabolites in feces including butyric, iso-valeric, caproic and vaccenic acids. No major changes were observed for the fecal BA profile following CG intervention. In summary, our work reveals new potential bacterial genera and gut microbiota-derived metabolites characterizing the interaction between an insoluble dietary fiber -CG- and the gut microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 膳食纤维被认为对健康有益。当前数据表明它们与肠道菌群的相互作用在很大程度上促进了它们的生理作用。在这种情况下，几丁质葡聚糖（CG）改善了与肥胖相关的小鼠代谢紊乱，但其对肠道菌群的作用尚未在人类中进行评估。这项研究探讨了在健康个体中进行为期3周的CG干预干预对肠道菌群组成和细菌代谢产物的影响。CG补充了健康志愿者（n=15）三周（4.5g/天）。分析了食物日记，视觉类似物和布里斯托尔的粪便形式量表以及“生活质量”调查。在肠道微生物群衍生的代谢产物中，对粪便样品中的胆汁酸（BA），长链和短链脂肪酸（LCFA，SCFA）进行了分析。通过Illumina测序分析肠道菌群（主要结局）。在健康人中，对CG的3周补充剂耐受良好。CG诱导肠道菌群组成发生特定变化，其中Eubacterium，Dorea和Roseburia属显示出最强的调节作用。另外，CG增加了粪便中的细菌代谢产物，包括丁酸，等戊酸，己酸和痘苗酸。在CG干预后，未观察到粪便BA曲线的重大变化。总之，我们的工作揭示了新的潜在细菌属和肠道菌群衍生的代谢产物，这些代谢产物表征了不溶性膳食纤维-CG-和肠道菌群之间的相互作用。</p>

<h2>Pubmed_ID: 32887539</h2>

<h3>Lactose-reduced infant formula with added corn syrup solids is associated with a distinct gut microbiota in Hispanic infants</h3>

<h3>乳糖减少的婴儿配方奶粉加上玉米糖浆固体成分与西班牙裔婴儿中独特的肠道菌群相关</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1813534</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32887539/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Infant formula feeding, compared with human milk, has been associated with development of a distinct infant gut microbiome, but no previous study has examined effects of formula with added sugars. This work examined differences in gut microbiota among 91 Hispanic infants who consumed human milk [at breast (BB) vs. pumped in bottle (BP)] and 2 kinds of infant formula [(traditional lactose-based (TF) vs. lactose-reduced with added sugar (ASF)]. At 1 and 6 months, infant stool was collected to characterize gut microbiota. At 6 months, mothers completed 24-hour dietary recalls and questionnaires to determine infant consumption of human milk (BB vs. BP) or formula (TF vs. ASF). Linear regression models were used to determine associations of milk consumption type and microbial features at 6 months. Infants in the formula groups exhibited a significantly more 'mature' microbiome than infants in the human milk groups with the most pronounced differences observed between the ASF vs. BB groups. In the ASF group, we observed reduced log-normalized abundance of Bifidobacteriaceae (TF-BB Mean Difference = -0.71, ASF-BB Mean Difference = -1.10), and increased abundance of Lachnospiraceae (TF-BB Mean Difference = +0.89, ASF-BB Mean Difference = +1.20). We also observed a higher Community Phenotype Index of propionate, most likely produced by Lachnospiraceae, in the ASF group (TF-BB Mean Difference = +0.27, ASF-BB Mean Difference = +0.36). This study provides the first evidence that consumption of infant formula with added sugar may have a stronger association than birth delivery mode, infant caloric intake, and maternal BMI on the infant's microbiome at 6 months of age.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 与母乳相比，婴儿配方食品的喂养与独特的婴儿肠道微生物组的发展有关，但是以前没有研究检查添加糖的配方食品的效果。这项工作研究了91名西班牙裔婴儿中肠道菌群的差异，这些婴儿在母乳中食用[母乳（BB）与在瓶中抽奶（BP）]和2种婴儿配方奶粉[（传统乳糖基（TF）与乳糖减少）在第1和6个月时，收集婴儿粪便以表征肠道菌群。在6个月时，母亲完成24小时的饮食召回和问卷调查，以确定婴儿的母乳消耗量（BBvs.BP）或（TFvs.ASF）。线性回归模型用于确定6个月时的牛奶摄入类型和微生物特征之间的关系。配方奶粉组中婴儿的“成熟”微生物组明显多于婴儿奶粉组中婴儿的“成熟”微生物组。在ASF组和BB组之间观察到明显的差异。在ASF组中，我们观察到双歧杆菌科的对数归一化的丰度降低（TF-BB平均差异=-0.71，ASF-BB平均差异=-1.10），斜纹藻科的丰度增加（TF-BB平均差=+0.89，ASF-BB平均差=+1.20）。我们还观察到在ASF组中丙酸的群落表型指数更高，最有可能由斜纹菌科产生（TF-BB平均差异=+0.27，ASF-BB平均差异=+0.36）。这项研究提供了第一个证据，即与分娩方式，婴儿热量摄入和6个月大时婴儿的微生物组中的母亲BMI相比，食用含糖的婴儿配方食品可能具有更强的关联性。</p>

<h2>Pubmed_ID: 32865119</h2>

<h3>Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection</h3>

<h3>肠道共生菌群和肠杆菌科细菌尿症和尿路感染的风险降低</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1805281</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32865119/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Urinary tract infection (UTI) is a common complication in kidney transplant recipients and can lead to significant morbidity and mortality. Recent evidence supports a role for the gut as a source for UTIs but little is known about the relationship between gut commensal bacteria and UTI development. We hypothesized that the abundance of gut commensal bacteria is associated with a lower risk of developing bacteriuria and UTIs. We performed gut microbiome profiling using 16S rRNA gene sequencing of the V4-V5 hypervariable region on 510 fecal specimens in 168 kidney transplant recipients. Fifty-one kidney transplant recipients (30%) developed Enterobacteriaceae bacteriuria within the first 6 months after transplantation (Enterobacteriaceae Bacteriuria Group) and 117 did not (No Enterobacteriaceae Bacteriuria Group). The relative abundances of Faecalibacterium and Romboutsia were significantly higher in the fecal specimens from the No Enterobacteriaceae Bacteriuria Group than those from the Enterobacteriaceae Bacteriuria Group (Adjusted P value<.01). The combined relative abundance of Faecalibacterium and Romboutsia was inversely correlated with the relative abundance of Enterobacteriaceae (r = -0.13, P = .003). In a multivariable Cox Regression, a top tercile cutoff of the combined relative abundance of Faecalibacterium and Romboutsia of ≥13.7% was independently associated with a decreased risk for Enterobacteriaceae bacteriuria (hazard ratio 0.3, P = .02) and Enterobacteriaceae UTI (hazard ratio 0.4, P = .09). In conclusion, we identify bacterial taxa associated with decreased risk for Enterobacteriaceae bacteriuria and Enterobacteriaceae UTI in kidney transplant recipients, which supports future studies on modulating the gut microbiota as a novel treatment for preventing UTIs.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尿路感染（UTI）是肾移植患者的常见并发症，可导致明显的发病率和死亡率。最近的证据支持肠道作为UTI的来源，但对肠道共生细菌与UTI发展之间关系的了解甚少。我们假设肠道共生细菌的丰富与细菌尿症和泌尿道感染的风险降低有关。我们在168个肾脏移植受者的510个粪便标本上使用V4-V5高变区的16SrRNA基因测序对肠道微生物组进行了分析。51名肾脏移植受者（30％）在移植后的前6个月内发展了肠杆菌科细菌（肠杆菌科细菌性尿杆菌群），而117例则没有（肠杆菌科细菌性尿杆菌群）。No.EnterobacteriaceaeaeBacteriuria组的粪便标本中Faecalibacter和Romboutsia的相对丰度显着高于EnterobacteriaceaeBacteriuria组的粪便标本（校正后的P值<.01）。Faecalibacterium和Rom​​boutsia的总相对丰度与肠杆菌科的相对丰度呈负相关（r=-0.13，P=.003）。在多变量Cox回归中，费氏细菌和罗氏菌的相对相对丰度最高的临界截止值≥13.7％与降低肠杆菌科细菌尿的风险（危险比0.3，P=.02）和肠杆菌科尿路感染（危险比0.4）相关。，P=.09）。总之，我们确定了与肾脏移植受者肠杆菌科细菌尿杆菌和肠杆菌科尿路感染的风险降低相关的细菌类群，这为将来调节肠道菌群作为预防尿路感染的新方法提供了支持。</p>

<h2>Pubmed_ID: 32845788</h2>

<h3>Modulation of gut microbiota in healthy rats after exposure to nutritional supplements</h3>

<h3>暴露于营养补充剂后健康大鼠肠道菌群的调节</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1779002</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32845788/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Introduction: Rats are experimental animals, frequently used as model organisms in the biomedical studies, and increasingly used to study the gut microbiota. Specifically, the aim of latter studies is either the elucidation of relationship between intestinal dysbiosis and diseases or the determination of nutrients or pharmaceutical agents which can cause the modulation in the presence or abundance of gut microbiota. Aim: Herein, the research studies conducted on the gut microbiota of healthy rats are presented in a summarized and concise overview. The focus is on studies aimed to reveal the shifts in microbial composition and functional changes after exposure to various types of nutritional supplements. Methods: We performed the search of PubMed database using the term "rat gut microbiome microbiota" and examined studies aimed to assess the composition of gut microbiota in physiological homeostasis as well as the effect of various nutritional supplements on the gut microbiota of healthy rats.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 简介：大鼠是实验动物，在生物医学研究中经常用作模型生物，并越来越多地用于研究肠道菌群。具体而言，后一研究的目的是阐明肠道营养不良与疾病之间的关系，或者确定可能导致肠道菌群存在或丰富的调节的营养素或药物。目的：在本文中，对健康大鼠的肠道菌群进行的研究总结在简明扼要的概述中。重点是旨在揭示暴露于各种类型营养补品后微生物成分变化和功能变化的研究。方法：我们使用术语“大鼠肠道微生物组微生物群”进行PubMed数据库搜索，并检查了旨在评估生理稳态中肠道微生物群组成以及各种营养补充剂对健康大鼠肠道微生物群的影响的研究。</p>

<h2>Pubmed_ID: 32844722</h2>

<h3>Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis</h3>

<h3>治疗前的禁食可减慢上皮周转并调节微生物群，但不能缓解甲氨蝶呤引起的胃肠道粘膜炎</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1809332</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32844722/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Recent findings by Tang et al. (2020) show dietary restriction (30%, 2 weeks) prevents methotrexate-induced mortality by modulation of the microbiota, specifically the expansion of Lactobacillus. While fundamentally insightful, upscaling this schedule is a major obstacle to clinical uptake. Here, we evaluate a safe and clinically achievable schedule of pre-therapy fasting for 48 h on microbiota composition, body composition and intestinal proliferation, and assess its impact on the severity of methotrexate-induced gastrointestinal mucositis using a validated preclinical rat model. Methods: Age- and weight-matched male Wistar rats were treated with a sublethal dose of 45 mg/kg methotrexate with or without pre-therapy fasting. The impact of acute fasting on epithelial proliferation, body composition and the microbiota was assessed using plasma citrulline, Ki67 immunohistochemistry, miniSpec and 16S rRNA sequencing. The severity of gastrointestinal mucositis was evaluated using plasma citrulline and body weight. Results: Whilst pre-therapy fasting slowed epithelial proliferation and increased microbial diversity and richness, it also induced significant weight loss and was unable to attenuate the severity of mucositis in both age- and weight-matched groups. In contrast to Tang et al., we saw no expansion of Lactobacillus following acute fasting. Conclusions: Our findings suggest that the beneficial effects of acute fasting are masked by the detrimental effects on body weight and composition and lacking influence on Lactobacillus. Future studies should consider alternative fasting schedules or aim to induce comparable microbial and mucosal manipulation without compromising body composition using clinically feasible methods of dietary or microbial intervention.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：Tang等人的最新发现。（2020年）显示饮食限制（30％，2周）可通过调节微生物群（特别是乳杆菌的膨胀）来防止甲氨蝶呤致死。虽然从根本上具有洞察力，但扩大此时间表是临床吸收的主要障碍。在这里，我们评估禁食前48小时对微生物群组成，身体组成和肠道增殖的安全且临床上可实现的时间表，并使用经过验证的临床前大鼠模型评估其对甲氨蝶呤诱发的胃肠道粘膜炎严重程度的影响。方法：年龄和体重相匹配的雄性Wistar大鼠以亚致死剂量45mg/kg甲氨蝶呤治疗，禁食或不禁食。使用血浆瓜氨酸，Ki67免疫组织化学，miniSpec和16SrRNA测序评估了急性禁食对上皮增殖，身体成分和微生物群的影响。使用血浆瓜氨酸和体重评估胃肠道粘膜炎的严重程度。结果：尽管禁食可以减缓上皮细胞的增殖，增加微生物的多样性和丰富性，但它也引起体重的明显减轻，并且不能减轻年龄和体重匹配组的粘膜炎的严重性。与Tang等人相反，我们发现急性禁食后乳酸杆菌没有扩增。结论：我们的发现表明，急性禁食的有益作用被体重和组成的不利影响所掩盖，而对乳杆菌缺乏影响。未来的研究应考虑替代性的禁食时间表，或旨在通过临床上可行的饮食或微生物干预方法，在不损害人体成分的前提下诱导类似的微生物和粘膜操作。</p>

<h2>Pubmed_ID: 32839304</h2>

<h3>Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis</h3>

<h3>多发性硬化症不同阶段肠道生态和功能微环境的改变</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1073/pnas.2011703117</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32839304/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Proceedings of the National Academy of Sciences of the United States of America  {'ISSN': '0027-8424', 'Name': 'proceedings of the national academy of sciences of the united states of america', '2015': '9.423', '2016': '9.661', '2017': '9.504', '2018': '9.58', '2019': '9.412'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 09/08/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Multiple sclerosis (MS), an autoimmune disease of the central nervous system, generally starts as the relapsing remitting form (RRMS), but often shifts into secondary progressive MS (SPMS). SPMS represents a more advanced stage of MS, characterized by accumulating disabilities and refractoriness to medications. The aim of this study was to clarify the microbial and functional differences in gut microbiomes of the different stages of MS. Here, we compared gut microbiomes of patients with RRMS, SPMS, and two closely related disorders with healthy controls (HCs) by 16S rRNA gene and whole metagenomic sequencing data from fecal samples and by fecal metabolites. Each patient group had a number of species having significant changes in abundance in comparison with HCs, including short-chain fatty acid (SCFA)-producing bacteria reduced in MS. Changes in some species had close association with clinical severity of the patients. A marked reduction in butyrate and propionate biosynthesis and corresponding metabolic changes were confirmed in RRMS compared with HCs. Although bacterial composition analysis showed limited differences between the patient groups, metagenomic functional data disclosed an increase in microbial genes involved in DNA mismatch repair in SPMS as compared to RRMS. Together with an increased ratio of cysteine persulfide to cysteine in SPMS revealed by sulfur metabolomics, we postulate that excessive DNA oxidation could take place in the gut of SPMS. Thus, gut ecological and functional microenvironments were significantly altered in the different stages of MS. In particular, reduced SCFA biosynthesis in RRMS and elevated oxidative level in SPMS were characteristic.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 多发性硬化症（MS）是中枢神经系统的一种自身免疫性疾病，通常以复发缓解形式（RRMS）开始，但通常会转变为继发性进行性MS（SPMS）。SPMS代表了MS的更高级阶段，其特征是累积的残疾和药物的难治性。这项研究的目的是澄清不同阶段MS肠道微生物区系的微生物和功能差异。在这里，我们通过16SrRNA基因和粪便样品及粪便代谢产物的全宏基因组测序数据，比较了RRMS，SPMS和两种与健康对照（HCs）有密切关系的疾病的患者肠道菌群。每个患者组都有许多与HCs相比丰度有明显变化的物种，包括MS中减少的产生短链脂肪酸（SCFA）的细菌。一些物种的变化与患者的临床严重程度密切相关。与HCs相比，在RRMS中证实了丁酸和丙酸生物合成的显着减少以及相应的代谢变化。尽管细菌成分分析显示患者组之间的差异有限，但宏基因组学功能数据显示与RRMS相比，SPMS中DNA错配修复涉及的微生物基因增加。加上硫代谢组学揭示了SPMS中半胱氨酸与半胱氨酸的比率增加，我们推测SPMS的肠道中可能发生过度的DNA氧化。因此，肠道的生态和功能微环境在MS的不同阶段发生了显着变化。特别是，RRMS中SCFA生物合成减少和SPMS中氧化水平升高是特征。</p>

<h2>Pubmed_ID: 32835617</h2>

<h3>The effects of dairy and dairy derivatives on the gut microbiota: a systematic literature review</h3>

<h3>乳制品和乳制品衍生物对肠道菌群的影响：系统文献综述</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1799533</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32835617/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The effects of dairy and dairy-derived products on the human gut microbiota remains understudied. A systematic literature search was conducted using Medline, CINAHL, Embase, Scopus, and PubMed databases with the aim of collating evidence on the intakes of all types of dairy and their effects on the gut microbiota in adults. Risk of bias was assessed using the Cochrane risk-of-bias tool.The search resulted in 6,592 studies, of which eight randomized controlled trials (RCTs) met pre-determined eligibility criteria for inclusion, consisting of a total of 468 participants. Seven studies assessed the effect of type of dairy (milk, yogurt, and kefir) and dairy derivatives (whey and casein) on the gut microbiota, and one study assessed the effect of the quantity of dairy (high dairy vs low dairy). Three studies showed that dairy types consumed (milk, yogurt, and kefir) increased the abundance of beneficial genera Lactobacillus and Bifidobacterium. One study showed that yogurt reduced the abundance of Bacteroides fragilis, a pathogenic strain. Whey and casein isolates and the quantity of dairy consumed did not prompt changes to the gut microbiota composition. All but one study reported no changes to bacterial diversity in response to dairy interventions and one study reported reduction in bacterial diversity in response to milk intake.In conclusion, the results of this review suggest that dairy products such as milk, yogurt, and kefir may modulate the gut microbiota composition in favor to the host. However, the broader health implications of these findings remain unclear and warrant further studies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 乳制品和乳制品衍生产品对人类肠道菌群的影响尚待研究。使用Medline，CINAHL，Embase，Scopus和PubMed数据库进行了系统的文献检索，目​​的是收集各种类型乳制品的摄入量及其对成年人肠道菌群的影响的证据。使用Cochrane偏见风险工具评估了偏见风险。该搜索结果进行了6,592项研究，其中八项随机对照试验（RCT）符合预定的纳入标准，总共468名参与者。七项研究评估了乳制品类型（牛奶，酸奶和开菲尔）和乳制品衍生物（乳清蛋白和酪蛋白）对肠道菌群的影响，一项研究评估了乳制品数量的影响（高乳制品与低乳制品）。三项研究表明，食用的乳制品类型（牛奶，酸奶和开菲尔）增加了有益的乳酸杆菌和双歧杆菌属的数量。一项研究表明，酸奶可以减少致病菌株脆弱拟杆菌（Bacteroidesfragilis）的含量。乳清和酪蛋白分离物以及食用的乳制品数量并未提示肠道微生物群组成发生变化。除一项研究外，所有研究均未报告对乳制品干预措施引起的细菌多样性变化，而另一项研究报告对摄入乳汁引起的细菌多样性降低。总而言之，本评价的结果表明，乳制品如牛奶，酸奶和开菲尔可能调节肠道菌群组成，使其对宿主有利。然而，这些发现对健康的广泛影响尚不清楚，需要进一步研究。</p>

<h2>Pubmed_ID: 32835590</h2>

<h3>Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health</h3>

<h3>系统发育多样的真细菌属的肠道微生物及其对肠道健康的各种贡献</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1802866</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32835590/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Over the last two decades our understanding of the gut microbiota and its contribution to health and disease has been transformed. Among a new 'generation' of potentially beneficial microbes to have been recognized are members of the genus Eubacterium, who form a part of the core human gut microbiome. The genus consists of phylogenetically, and quite frequently phenotypically, diverse species, making Eubacterium a taxonomically unique and challenging genus. Several members of the genus produce butyrate, which plays a critical role in energy homeostasis, colonic motility, immunomodulation and suppression of inflammation in the gut. Eubacterium spp. also carry out bile acid and cholesterol transformations in the gut, thereby contributing to their homeostasis. Gut dysbiosis and a consequently modified representation of Eubacterium spp. in the gut, have been linked with various human disease states. This review provides an overview of Eubacterium species from a phylogenetic perspective, describes how they alter with diet and age and summarizes its association with the human gut and various health conditions.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在过去的二十年中，我们对肠道菌群及其对健康和疾病的贡献的认识已经转变。公认的新一代潜在有益微生物是真细菌属的成员，它们构成人类核心肠道微生物组的一部分。该属包括系统发育的，并且在表型上经常是多种多样的物种，使真细菌成为分类学上独特且具有挑战性的属。该属的几个成员产生丁酸酯，丁酸酯在能量稳态，结肠运动，免疫调节和肠道炎症抑制中起关键作用。真细菌还会在肠道中进行胆汁酸和胆固醇的转化，从而促进其体内稳态。肠道营养不良，并因此修饰了真细菌属。在肠道中，已经与各种人类疾病状态相关联。这篇综述从系统发育的角度概述了真细菌，描述了它们如何随着饮食和年龄而变化，并总结了其与人类肠道和各种健康状况的关系。</p>

<h2>Pubmed_ID: 32816619</h2>

<h3>Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease</h3>

<h3>在治疗非酒精性脂肪性肝病中，修饰大量营养素优于微生物组移植</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1792256</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32816619/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver injury and liver transplantation in Western countries. The pathogenesis of NAFLD includes overnutrition-associated metabolic syndrome or the improper consumption of dietary macro- and micro-nutrients that either support or prevent disease development. This altered nutrient landscape has been linked to shifts within the gut microbiota which can exacerbate liver pathology and the progression of NAFLD. Treatment goals for NAFLD target lifestyle and dietary modifications that restrict calories and adjust macronutrient content. It is not well understood how different macronutrients alter the microbiota and whether the diet-educated microbiota contribute to the resolution of disease. We fed mice a diet high in fat, cholesterol and fructose for 6 weeks and then in two different arms of the study, intervened with either a diet high in saturated and polyunsaturated fats and fiber or low in fats and fiber. In a second set of experiments, we performed microbiota transplants using cecal contents from mice fed one of the intervention diets to assess whether the diet-educated microbiota could impact clinical outcomes in mice fed a NAFLD-inducing diet. Pathology, steatosis, ALT/AST levels, and liver cytokine levels were measured as primary outcomes. We found that despite different microbiota compositions, both of the intervention diets reversed the progression of NAFLD and dampened inflammation. In contrast, transplantation of cecal contents from the intervention diet-fed mice to mice receiving a NAFLD-inducing diet was unable to prevent disease progression, and, in some cases, worsened disease. These data underscore the importance of dietary modifications to treat NAFLD and caution against the use of microbiota transplantation in the absence of dietary and lifestyle modifications.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 非酒精性脂肪肝疾病（NAFLD）是西方国家慢性肝损伤和肝移植的主要原因。NAFLD的发病机制包括与营养过度相关的代谢综合症，或不适当消耗支持或预防疾病发展的饮食中大量和微量营养素。营养素格局的这种变化与肠道菌群内的变化有关，这会加剧肝脏病理和NAFLD的进展。NAFLD的治疗目标针对限制卡路里和调节常量营养素含量的生活方式和饮食习惯。人们尚不了解不同的常量营养素如何改变微生物群，以及饮食中培养的微生物群是否有助于疾病的解决。我们给小鼠喂了高脂肪，高胆固醇和果糖的饮食，持续了6周，然后在研究的两个不同方面进行了干预，干预方式是高饱和和多不饱和脂肪和纤维的饮食或低脂肪和纤维的饮食。在第二组实验中，我们使用饲喂一种干预饮食的小鼠的盲肠内容物进行了微生物菌群移植，以评估饮食诱导的微生物菌群是否会影响喂养NAFLD诱导饮食的小鼠的临床结局。病理，脂肪变性，ALT/AST水平和肝细胞因子水平被作为主要结局进行了测量。我们发现，尽管微生物群组成不同，但两种干预饮食均能逆转NAFLD的进展并减轻炎症。相比之下，将盲肠内容物从干预饮食喂养的小鼠移植到接受NAFLD诱导饮食的小鼠不能预防疾病进展，在某些情况下还可以防止疾病恶化。这些数据强调了饮食调整对治疗NAFLD的重要性，并警告在没有饮食和生活方式调整的情况下不要使用微生物菌群移植。</p>

<h2>Pubmed_ID: 32804018</h2>

<h3>The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet</h3>

<h3>代谢性内毒素血症的发展取决于甜味剂的类型和饮食中饱和脂肪的存在</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1801301</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32804018/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Fat and sweeteners contribute to obesity. However, it is unknown whether specific bacteria are selectively modified by different caloric and noncaloric sweeteners with or without a high-fat diet (HFD). Here, we combined extensive host phenotyping and shotgun metagenomics of the gut microbiota to investigate this question. We found that the type of sweetener and its combination with an HFD selectively modified the gut microbiota. Sucralose and steviol glycosides led to the lowest α-diversity of the gut microbiota. Sucralose increased the abundance of B. fragilis in particular, resulting in a decrease in the abundance of occludin and an increase in proinflammatory cytokines, glucose intolerance, fatty acid oxidation and ketone bodies. Sucrose+HFD showed the highest metabolic endotoxemia, weight gain, body fat, total short chain fatty acids (SCFAs), serum TNFα concentration and glucose intolerance. Consumption of sucralose or sucrose resulted in enrichment of the bacterial genes involved in the synthesis of LPS and SCFAs. Notably, brown sugar and honey were associated with the absence of metabolic endotoxemia, increases in bacterial gene diversity and anti-inflammatory markers such as IL-10 and sIgA, the maintenance of glucose tolerance and energy expenditure, similar to the control group, despite the consumption of an HFD. These findings indicate that the type of sweetener and an HFD selectively modify the gut microbiota, bacterial gene enrichment of metabolic pathways involved in LPS and SCFA synthesis, and metabolic endotoxemia associated with different metabolic profiles.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 脂肪和甜味剂有助于肥胖。然而，未知特定的细菌是否被高热量饮食（HFD）或不含高脂肪饮食（HFD）的不同热量和非热量甜味剂选择性地修饰。在这里，我们结合了肠道菌群的广泛宿主表型和shot弹枪宏基因组学来研究这个问题。我们发现甜味剂的类型及其与HFD的组合选择性地修饰了肠道菌群。三氯蔗糖和甜菊醇苷导致肠道菌群的最低α-多样性。三氯蔗糖尤其增加了脆弱脆弱芽孢杆菌的丰度，导致闭合蛋白的丰度降低，促炎细胞因子，葡萄糖耐受不良，脂肪酸氧化和酮体增加。蔗糖+HFD表现出最高的代谢内毒素血症，体重增加，体脂，总短链脂肪酸（SCFA），血清TNFα浓度和葡萄糖耐受不良。三氯蔗糖或蔗糖的消耗导致参与LPS和SCFA合成的细菌基因的富集。值得注意的是，与对照组类似，红糖和蜂蜜与缺乏代谢性内毒素血症，细菌基因多样性增加和抗炎标记物（如IL-10和sIgA），维持葡萄糖耐量和能量消耗有关，与对照组相关。HFD的消耗。这些发现表明，甜味剂和HFD的类型可选择性地改变肠道菌群，参与LPS和SCFA合成的代谢途径的细菌基因富集以及与不同代谢谱相关的代谢性内毒素血症。</p>

<h2>Pubmed_ID: 32795243</h2>

<h3>Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens</h3>

<h3>肠道和类器官的时代研究：人类肠道模型如何改变了肠道细菌病原体的研究</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1795389</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32795243/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Enteric bacterial pathogens cause significant morbidity and mortality globally. Studies in tissue culture and animal models shaped our initial understanding of these host-pathogen interactions. However, intrinsic shortcomings in these models limit their application, especially in translational applications like drug screening and vaccine development. Human intestinal enteroid and organoid models overcome some limitations of existing models and advance the study of enteric pathogens. In this review, we detail the use of human enteroids and organoids to investigate the pathogenesis of invasive bacteria Shigella, Listeria, and Salmonella, and noninvasive bacteria pathogenic Escherichia coli, Clostridium difficile, and Vibrio cholerae. We highlight how these studies confirm previously identified mechanisms and, importantly, reveal novel ones. We also discuss the challenges for model advancement, including platform engineering to integrate environmental conditions, innate immune cells and the resident microbiome, and the potential for pre-clinical testing of recently developed antimicrobial drugs and vaccines.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道细菌性病原体在全球范围内引起大量发病和死亡。在组织培养和动物模型中的研究塑造了我们对这些宿主-病原体相互作用的初步了解。但是，这些模型的固有缺陷限制了它们的应用，尤其是在诸如药物筛选和疫苗开发等转化应用中。人肠小肠和类器官模型克服了现有模型的某些局限性，并促进了肠道病原体的研究。在这篇综述中，我们详细介绍了人类小肠类和类器官的使用，以研究侵袭性细菌志贺氏菌，李斯特菌和沙门氏菌，以及非侵入性细菌致病性大肠杆菌，艰难梭菌和霍乱弧菌的发病机理。我们重点介绍这些研究如何确认先前确定的机制，并且重要的是揭示新颖的机制。我们还讨论了模型开发所面临的挑战，包括整合环境条件，先天免疫细胞和驻留微生物组的平台工程，以及对最近开发的抗菌药物和疫苗进行临床前测试的潜力。</p>

<h2>Pubmed_ID: 32783770</h2>

<h3>Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity</h3>

<h3>肠道菌群来源的色氨酸代谢产物可预测Ah受体的活性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788899</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32783770/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Commensal microbiota-dependent tryptophan catabolism within the gastrointestinal tract is known to exert profound effects upon host physiology, including the maintenance of epithelial barrier and immune function. A number of abundant microbiota-derived tryptophan metabolites exhibit activation potential for the aryl hydrocarbon receptor (AHR). Gene expression facilitated by AHR activation through the presence of dietary or microbiota-generated metabolites can influence gastrointestinal homeostasis and confer protection from intestinal challenges. Utilizing untargeted mass spectrometry-based metabolomics profiling, combined with AHR activity screening assays, we identify four previously unrecognized tryptophan metabolites, present in mouse cecal contents and human stool, with the capacity to activate AHR. Using GC/MS and LC/MS platforms, quantification of these novel AHR activators, along with previously established AHR-activating tryptophan metabolites, was achieved, providing a relative order of abundance. Using physiologically relevant concentrations and quantitative gene expression analyses, the relative efficacy of these tryptophan metabolites with regard to mouse or human AHR activation potential is examined. These data reveal indole, 2-oxindole, indole-3-acetic acid and kynurenic acid as the dominant AHR activators in mouse cecal contents and human stool from participants on a controlled diet. Here we provide the first documentation of the relative abundance and AHR activation potential of a panel of microbiota-derived tryptophan metabolites. Furthermore, these data reveal the human AHR to be more sensitive, at physiologically relevant concentrations, to tryptophan metabolite activation than mouse AHR. Additionally, correlation analyses indicate a relationship linking major tryptophan metabolite abundance with AHR activity, suggesting these cecal/fecal metabolites represent biomarkers of intestinal AHR activity.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 胃肠道内的共生微生物依赖性色氨酸分解代谢对宿主生理产生深远影响，包括维持上皮屏障和免疫功能。许多丰富的微生物来源的色氨酸代谢物表现出芳烃受体（AHR）的激活潜力。通过饮食或微生物产生的代谢产物的存在，由AHR激活而促进的基因表达可以影响胃肠道的稳态，并提供免受肠道挑战的保护。利用基于非靶向质谱的代谢组学分析，结合AHR活性筛选测定，我们确定了小鼠盲肠内容物和人类粪便中存在的四种先前无法识别的色氨酸代谢物，具有激活AHR的能力。使用GC/MS和LC/MS平台，可以对这些新型AHR活化剂以及先前建立的AHR活化色氨​​酸代谢产物进行定量，从而提供相对的丰度顺序。使用生理学相关浓度和定量基因表达分析，检查了这些色氨酸代谢物对小鼠或人AHR激活潜能的相对功效。这些数据表明，在饮食控制下的小鼠盲肠内容物和人类粪便中，吲哚，2-羟吲哚，吲哚-3-乙酸和犬尿酸是主要的AHR激活剂。在这里，我们提供了一组微生物群衍生的色氨酸代谢物的相对丰度和AHR活化潜力的第一个文献。此外，这些数据表明，在生理相关浓度下，人AHR比小鼠AHR对色氨酸代谢物的活化更为敏感。另外，相关性分析表明主要色氨酸代谢物丰度与AHR活性之间存在关联，表明这些盲肠/粪便代谢物代表了肠道AHR活性的生物标志物。</p>

<h2>Pubmed_ID: 32779963</h2>

<h3>Vitamin D supplementation in pregnancy and early infancy in relation to gut microbiota composition and C. difficile colonization: implications for viral respiratory infections</h3>

<h3>妊娠和婴儿期补充维生素D与肠道菌群组成和艰难梭菌定植有关：对病毒性呼吸道感染的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1799734</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32779963/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: In Canada and the US, the infant diet is supplemented with vitamin D via supplement drops or formula. Pregnant and nursing mothers often take vitamin D supplements. Since little is known about the impact of this supplementation on infant gut microbiota, we undertook a study to determine the association between maternal and infant vitamin D supplementation, infant gut microbiota composition and Clostridioides difficile colonization in 1,157 mother-infant pairs of the CHILD (Canadian Healthy Infant Longitudinal Development) Cohort Study over 2009-2012. Logistic and MaAsLin regression were employed to assess associations between vitamin D supplementation, and C. difficile colonization, or other gut microbiota, respectively. Sixty-five percent of infants received a vitamin D supplement. Among all infants, infant vitamin D supplementation was associated with a lower abundance of genus Megamonas (q = 0.01) in gut microbiota. Among those exclusively breastfed, maternal prenatal supplementation was associated with lower abundance of Bilophila (q = 0.01) and of Lachnospiraceae (q = 0.02) but higher abundance of Haemophilus (q = 0.02). There were no differences in microbiota composition with vitamin D supplementation among partially and not breastfed infants. Neither infant nor maternal vitamin D supplementation were associated with C. difficile colonization, after adjusting for breastfeeding status and other factors. However, maternal consumption of vitamin-D fortified milk reduced the likelihood of C. difficile colonization in infants (adjustedOR: 0.40, 95% CI: 0.19-0.82). The impact of this compositional difference on later childhood health, especially defense against viral respiratory infection, may go beyond the expected effects of vitamin D supplements and remains to be ascertained.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在加拿大和美国，婴儿膳食通过补充滴剂或配方奶粉补充了维生素D。孕妇和哺乳期母亲经常服用维生素D补充剂。由于对这种补充剂对婴儿肠道菌群的影响知之甚少，我们进行了一项研究，以确定在1,157对CHILD（加拿大）母婴对中母婴维生素D补充剂，婴儿肠道菌群组成与艰难梭菌定殖之间的关系。2009-2012年婴儿健康纵向发展队列研究。使用Logistic和MaAsLin回归分别评估补充维生素D与艰难梭菌定植或其他肠道菌群之间的关联。65％的婴儿接受了维生素D补充剂。在所有婴儿中，补充婴儿维生素D与肠道菌群中大单胞菌属（Megamonas）含量较低（q=0.01）有关。在那些纯母乳喂养的婴儿中，产前补充母亲的血友病菌（q=0.01）和漆鞭草科（q=0.02）较低，而嗜血杆菌属（q=0.02）较高。在部分和非母乳喂养的婴儿中，补充维生素D的微生物群组成没有差异。在调整母乳喂养状态和其他因素后，婴儿和母亲补充维生素D均与艰难梭菌定殖无关。但是，孕妇食用维生素D强化牛奶会降低婴儿艰难梭菌定植的可能性（调整OR：0.40，95％CI：0.19-0.82）。这种成分差异对儿童后期健康的影响，尤其是对病毒性呼吸道感染的防御作用，可能超出维生素D补充剂的预期效果，有待确定。</p>

<h2>Pubmed_ID: 32759302</h2>

<h3>The role of gut microbiota in cancer treatment: friend or foe?</h3>

<h3>肠道菌群在癌症治疗中的作用：敌是友？</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2020-321153</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32759302/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Oct</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint inhibitors (ICIs), whereas supplementation of distinct bacterial species restores responses to the anticancer drugs. Accumulating evidence has revealed the potential of modulating the gut microbiota to enhance the efficacy of anticancer drugs. Regardless of the valuable findings by preclinical models and clinical data of patients with cancer, a more thorough understanding of the interactions of the microbiota with cancer therapy helps researchers identify novel strategy for cancer prevention, stratify patients for more effective treatment and reduce treatment complication. In this review, we discuss the scientific evidence on the role of gut microbiota in cancer treatment, and highlight the latest knowledge and technologies leveraged to target specific bacteria that contribute to tumourigenesis. First, we provide an overview of the role of the gut microbiota in cancer, establishing the links between bacteria, inflammation and cancer treatment. Second, we highlight the mechanisms used by distinct bacterial species to modulate cancer growth, immune responses, as well as the efficacy of chemotherapeutic drugs and ICIs. Third, we demonstrate various approaches to modulate the gut microbiota and their potential in translational research. Finally, we discuss the limitations of current microbiome research in the context of cancer treatment, ongoing efforts to overcome these challenges and future perspectives.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群与癌症有关，并显示出可调节抗癌药的功效。肠道菌群的改变与对化学药物或免疫检查点抑制剂（ICI）的抗性有关，而补充独特的细菌可恢复对抗癌药物的反应。越来越多的证据表明，调节肠道菌群以增强抗癌药功效的潜力。不管癌症患者的临床前模型和临床数据有何宝贵发现，对微生物群与癌症治疗相互作用的更透彻了解有助于研究人员确定新的癌症预防策略，对患者进行分层以进行更有效的治疗并减少治疗并发症。在这篇综述中，我们讨论了肠道菌群在癌症治疗中的作用的科学证据，并重点介绍了可用于靶向特定细菌的最新知识和技术，这些细菌有助于肿瘤的发生。首先，我们概述了肠道菌群在癌症中的作用，建立了细菌，炎症和癌症治疗之间的联系。其次，我们重点介绍了不同细菌物种用于调节癌症生长，免疫应答以及化学治疗药物和ICI功效的机制。第三，我们展示了多种调节肠道菌群的方法及其在转化研究中的潜力。最后，我们讨论了当前微生物组研究在癌症治疗方面的局限性，为克服这些挑战而进行的持续努力以及未来的前景。</p>

<h2>Pubmed_ID: 32752913</h2>

<h3>Alternations of gut microbiota composition in neonates conceived by assisted reproductive technology and its relation to infant growth</h3>

<h3>辅助生殖技术对新生儿肠道菌群组成的改变及其与婴儿生长的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1794466</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32752913/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiome in newborns may be strongly influenced by their intrinsic host microenvironmental factors (e.g., the gestational age) and has been linked to their short-term growth and potentially future health. It is yet unclear whether early microbiota composition is significantly different in newborns conceived by assisted reproductive technology (ART) when compared with those who were conceived spontaneously. Additionally, little is known about the effect of gut microbiota composition on weight gain in early infancy. We aimed to characterize the features and the determinants of the gut microbiome in ART newborns and to assess the impact of early microbiota composition on their weight gain in early infancy in mother-infant dyads enrolled in the China National Birth Cohort (CNBC). Among 118 neonates born by ART and 91 neonates born following spontaneous conception, we observed significantly reduced gut microbiota α-diversity and declined Bacteroidetes relative abundance in ART neonates. The microbiota composition of ART neonates was largely driven by specific ART treatments, hinting the importance of fetus intrinsic host microenvironment on the early microbial colonization. Following up these neonates for six months after their births, we observed the effects of gut microbiome composition on infant rapid weight gaining. Collectively, we identified features and determinants of the gut microbiota composition in ART neonates, and provided evidence for the importance of microbiota composition in neonatal growth.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 新生儿的肠道微生物组可能会受到其内在的宿主微环境因素（例如胎龄）的强烈影响，并且与他们的短期生长和未来的健康状况有关。尚不清楚，与自然怀孕的婴儿相比，辅助生殖技术（ART）怀孕的婴儿的早期菌群组成是否显着不同。另外，关于婴儿早期肠道菌群组成对体重增加的影响知之甚少。我们旨在表征ART新生儿中肠道微生物组的特征和决定因素，并评估早期微生物群组成对其在中国出生队列（CNBC）中登记的母婴二代婴儿早期体重增加的影响。在ART出生的118例新生儿和自然受孕后的91例新生儿中，我们观察到ART新生儿的肠道菌群α多样性显着降低，拟杆菌的相对丰度下降。ART新生儿的微生物群组成很大程度上受特定的ART治疗驱动，这暗示了胎儿固有宿主微环境对早期微生物定殖的重要性。在这些新生儿出生后随访六个月，我们观察到肠道微生物组组成对婴儿快速增重的影响。我们共同确定了ART新生儿肠道菌群组成的特征和决定因素，并为微生物菌群组成在新生儿生长中的重要性提供了证据。</p>

<h2>Pubmed_ID: 32744162</h2>

<h3>The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota</h3>

<h3>胎粪菌群比羊粪菌群和阴道菌群具有更多的羊水菌群特征。</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1794266</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32744162/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The early-life gut microbiota is associated with potential development of diseases in adulthood. The sterile womb paradigm has been challenged by recent reports that revealed the presence of the meconium, amniotic fluid, and placenta microbiome. This study aimed to explore the maternal origin of the microbiota of neonate meconium by using the PacBio single-molecule real-time circular consensus sequencing technology. Such technology could produce high fidelity reads of full-length 16S rRNA genes, improving the sensitivity and specificity of taxonomic profiling. It also reduced the risk of false positives. This study analyzed the full-length 16S rRNA-based microbiota of maternal samples (amniotic fluid, feces, vaginal fluid, saliva) and first-pass meconium of 39 maternal-neonate pairs. Alpha- and beta-diversity analyses revealed sample type-specific microbiota features. Most sample types were dominated by sequences representing different genera (Lactobacillus and Curvibacter in the amniotic fluid and vaginal fluid microbiota; Bacillus and Escherichia/Shigella in the meconium microbiota; Bacteroides and Faecalibacterium in the maternal fecal microbiota; Streptococcus and Prevotella in the maternal saliva microbiota). Moreover, specific operational taxonomic units (OTUs) were identified in all sample types. Dyad analysis revealed common OTUs between the meconium microbiota and microbiota of multiple maternal samples. The meconium microbiota shared more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota. Our results strongly suggested that the meconium microbiota was seeded from multiple maternal body sites, and the amniotic fluid microbiota contributed most to the seeding of the meconium microbiota among the investigated maternal body sites.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 早期肠道菌群与成年期疾病的潜在发展有关。最近的报道揭示了胎粪，羊水和胎盘微生物组的存在，对无菌子宫范例提出了挑战。本研究旨在通过使用PacBio单分子实时循环共有序列测序技术探索新生儿胎粪微生物群的母源。此类技术可以产生全长16SrRNA基因的高保真读数，从而提高分类学谱分析的敏感性和特异性。这也减少了误报的风险。这项研究分析了孕妇样品（羊水，粪便，阴道液，唾液）和39对孕妇新生儿配对的初次通过胎粪的全长16SrRNA基微生物区系。阿尔法和贝塔多样性分析揭示了样品类型特异性的微生物群特征。大多数样品类型由代表不同属的序列决定（羊水和阴道菌群中的乳酸杆菌和弯曲杆菌；胎粪菌群中的杆菌和大肠杆菌/志贺氏菌；产妇粪便菌群中的杆菌和费卡杆菌；孕妇唾液菌群中的链球菌和普氏杆菌。）。此外，在所有样本类型中都确定了特定的操作分类单位（OTU）。Dyad分析揭示了胎粪微生物群和多个母体样品的微生物群之间常见的OTU。羊水菌群比产妇粪便和阴道菌群具有更多的胎粪菌群特征。我们的结果有力地表明，胎粪微生物群是从多个孕产妇身体部位播种的，而羊水微生物群对所调查的孕产妇身体部位中胎粪微生物菌群的播种贡献最大。</p>

<h2>Pubmed_ID: 32730134</h2>

<h3>Dysbiosis in a canine model of human fistulizing Crohn's disease</h3>

<h3>人性克罗恩病犬模型中的生物失调</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785246</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32730134/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Crohn's disease (CD) is a chronic immune-mediated inflammatory condition caused by the loss of mucosal tolerance toward the commensal microbiota. On average, 29.5% and 42.7% CD patients experience perianal complications at 10 and 20 y after diagnosis, respectively. Perianal CD (pCD) result in high disease burden, diminished quality of life, and elevated health-care costs. Overall pCD are predictors of poor long-term outcomes. Animal models of gut inflammation have failed to fully recapitulate the human manifestations of fistulizing CD. Here, we evaluated dogs with spontaneous canine anal furunculosis (CAF), a disease with clinical similarities to pCD, as a surrogate model for understanding the microbial contribution of human pCD pathophysiology. By comparing the gut microbiomes between dogs suffering from CAF (CAF dogs) and healthy dogs, we show CAF-dog microbiomes are either very dissimilar (dysbiotic) or similar (healthy-like), yet unique, to healthy dog's microbiomes. Compared to healthy or healthy-like CAF microbiomes, dysbiotic CAF microbiomes showed an increased abundance of Bacteroides vulgatus and Escherichia coli and a decreased abundance of Megamonas species and Prevotella copri. Our results mirror what have been reported in previous microbiome studies of patients with CD; particularly, CAF dogs exhibited two distinct microbiome composition: dysbiotic and healthy-like, with determinant bacterial taxa such as E. coli and P. copri that overlap what it has been found on their human counterpart. Thus, our results support the use of CAF dogs as a surrogate model to advance our understanding of microbial dynamics in pCD.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 克罗恩氏病（CD）是一种慢性免疫介导的炎症性疾病，由粘膜对共生微生物的耐受力丧失引起。分别在诊断后10年和20年，平均有29.5％和42.7％的CD患者经历肛周并发症。肛周CD（pCD）导致高疾病负担，生活质量下降和医疗保健费用增加。总体pCD是长期不良预后的预测指标。肠道炎症的动物模型未能完全概括瘘管CD的人类表现。在这里，我们评估了具有自发性犬肛门肛门真菌病（CAF）（一种与pCD具有临床相似性的疾病）的狗，作为了解人类pCD病理生理的微生物贡献的替代模型。通过比较患有CAF的狗（CAF狗）和健康的狗之间的肠道微生物群，我们发现CAF狗的微生物群与健康犬的微生物群非常不同（营养不良）或相似（类似于健康），但独特。与健康或类似健康的CAF微生物组相比，营养不良的CAF微生物组显示寻常型拟杆菌和大肠杆菌的丰度增加，大摩纳哥物种和普氏杆菌的丰度降低。我们的结果反映了先前对CD患者进行的微生物组研究的报道。特别是，CAF狗表现出两种截然不同的微生物组组成：营养不良型和健康型，其决定性细菌类群（如大肠杆菌和柯氏疟原虫）与人类同类动物重叠。因此，我们的结果支持使用CAF狗作为替代模型，以增进我们对pCD中微生物动力学的理解。</p>

<h2>Pubmed_ID: 32715918</h2>

<h3>Toward a porcine in vivo model to analyze the pathogenesis of TLR5-dependent enteropathies</h3>

<h3>建立一个猪体内模型以分析TLR5依赖性肠病的发病机理</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782163</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32715918/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Non-communicable diseases, such as the metabolic syndrome and inflammatory bowel disease, constitute serious public health threats in developed countries. Besides environmental factors, genetic predispositions contribute to the onset and progression of the disease. State-of-the-art mouse models recently highlight the involvement of Toll-like receptor 5 (TLR5)-driven microbiota composition in the development of metabolic disorders. Here, we discuss the causes and consequences of an altered enteric microbiota and provide information on a similar mechanism in another species, the pig. We show for the first time that a single nucleotide polymorphism in the porcine TLR5 gene conferring impaired functionality is associated with changes in the intestinal microbiota in adult sows and neonatal piglets. Changes in the developing adaptive cellular immune response support the concept of TLR5-driven changes of the microbe-host interplay also in the pig. Together, these findings suggest that pigs with impaired TLR-functionality might represent a model for TLR5-driven diseases in humans.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 诸如代谢综合征和炎症性肠病等非传染性疾病在发达国家构成严重的公共卫生威胁。除环境因素外，遗传易感性也有助于疾病的发作和发展。最新的小鼠模型强调了Toll样受体5（TLR5）驱动的微生物群组成与代谢性疾病的发展有关。在这里，我们讨论肠微生物群改变的原因和后果，并提供有关另一种物种（猪）中类似机制的信息。我们首次显示，在猪TLR5基因中赋予功能受损的单核苷酸多态性与成年母猪和新生仔猪肠道菌群的变化有关。发育中的适应性细胞免疫反应的变化也支持了TLR5驱动的微生物与宿主之间相互作用的观念。总之，这些发现表明，TLR功能受损的猪可能代表了人类TLR5驱动疾病的模型。</p>

<h2>Pubmed_ID: 32691669</h2>

<h3>TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn's disease</h3>

<h3>从克罗恩病患者的小肠粘膜中鉴定出可诱导TH1细胞的大肠杆菌菌株</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788898</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32691669/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dysbiotic microbiota contributes to the pathogenesis of Crohn's disease (CD) by regulating the immune system. Although pro-inflammatory microbes are probably enriched in the small intestinal (SI) mucosa, most studies have focused on fecal microbiota. This study aimed to examine jejunal and ileal mucosal specimens from patients with CD via double-balloon enteroscopy. Comparative microbiome analysis revealed that the microbiota composition of CD SI mucosa differs from that of non-CD controls, with an increased population of several families, including Enterobacteriaceae, Ruminococcaceae, and Bacteroidaceae. Upon anaerobic culturing of the CD SI mucosa, 80 bacterial strains were isolated, from which 9 strains representing 9 distinct species (Escherichia coli, Ruminococcus gnavus, Klebsiella pneumoniae, Erysipelatoclostridium ramosum, Bacteroides dorei, B. fragilis, B. uniformis, Parabacteroides distasonis, and Streptococcus pasteurianus) were selected on the basis of their significant association with CD. The colonization of germ-free (GF) mice with the 9 strains enhanced the accumulation of TH1 cells and, to a lesser extent, TH17 cells in the intestine, among which an E. coli strain displayed high potential to induce TH1 cells and intestinal inflammation in a strain-specific manner. The present results indicate that the CD SI mucosa harbors unique pro-inflammatory microbiota, including TH1 cell-inducing E. coli, which could be a potential therapeutic target.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 营养不良微生物群通过调节免疫系统，促进了克罗恩病（CD）的发病。尽管促炎微生物可能在小肠（SI）粘膜中富集，但大多数研究都集中在粪便微生物群上。这项研究旨在通过双气囊肠镜检查来检查CD患者的空肠和回肠粘膜标本。对比微生物组分析显示，CDSI粘膜的微生物群组成与非CD对照相比有所不同，包括肠杆菌科，Ruminococcaceae和Bacteroidaceaceae在内的数个家庭的数量有所增加。在厌氧培养CDSI粘膜上，分离出80个细菌菌株，其中9个菌株代表9种不同的菌种（大肠杆菌，鲁美球菌，肺炎克雷伯菌，产气荚膜芽孢杆菌，Bacteroidesdorei，脆弱型芽孢杆菌，均匀芽孢杆菌，副细菌）链球菌和巴氏链球菌是根据它们与CD的显着相关性来选择的。用这9种菌株对无菌（GF）小鼠的定殖可增强肠道中TH1细胞的积累，并在较小程度上增强TH17细胞的积累，其中大肠杆菌菌株具有诱导TH1细胞和肠道炎症的高潜力以应变特定的方式。目前的结果表明，CDSI粘膜具有独特的促炎微生物菌群，包括诱导TH1细胞的大肠杆菌，这可能是潜在的治疗靶点。</p>

<h2>Pubmed_ID: 32686598</h2>

<h3>Gut microbiota regulate tumor metastasis via circRNA/miRNA networks</h3>

<h3>肠道菌群通过circRNA / miRNA网络调节肿瘤转移</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788891</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32686598/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Increasing evidence indicates that gut microbiota plays an important role in cancer progression. However, the underlying mechanism remains largely unknown. Here, we report that broad-spectrum antibiotics (ABX) treatment leads to enhanced metastasis by the alteration of gut microbiome composition. Methods: Cancer LLC and B16-F10 cell metastasis mouse models, and microarray/RNA sequencing analysis were used to reveal the regulatory functions of microbiota-mediated circular RNA (circRNA)/microRNA (miRNA) networks that may contribute to cancer metastasis. Results: The specific pathogen-free (SPF) mice with ABX treatment demonstrated enhanced lung metastasis. Fecal microbiota transplantation (FMT) from SPF mice or Bifidobacterium into germ-free mice significantly suppressed lung metastasis. Mechanistically, gut microbiota impacts circRNA expression to regulate levels of corresponding miRNAs. Specifically, such modulations of gut microbiota inhibit mmu_circ_0000730 expression in an IL-11-dependent manner. Bioinformatics analysis combined with luciferase reporter assays revealed reciprocal repression between mmu_circ_0000730 and mmu-miR-466i-3p. We further showed that both mmu-miR-466i-3p and mmu-miR-466 f-3p suppresses a number of genes involved in epithelial-mesenchymal transition (EMT) and stemness of cancer stem cells such as SOX9. Conclusions: These results provide evidence of a previously unrecognized regulatory role of non-coding RNAs in microbiota-mediated cancer metastasis, and thus, the microbiome may serve as a therapeutic target.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：越来越多的证据表明肠道菌群在癌症进展中起着重要作用。但是，基本机制仍然未知。在这里，我们报告说，广谱抗生素（ABX）治疗通过改变肠道微生物组组成导致转移增强。方法：使用癌症LLC和B16-F10细胞转移小鼠模型以及微阵列/RNA测序分析来揭示微生物群介导的环状RNA（circRNA）/microRNA（miRNA）网络的调控功能，这可能有助于癌症转移。结果：经过ABX处理的无特定病原体（SPF）小鼠表现出增强的肺转移能力。从SPF小鼠或双歧杆菌到无菌细菌的粪便微生物菌群移植（FMT）显着抑制了肺转移。从机制上讲，肠道菌群会影响circRNA的表达，从而调节相应miRNA的水平。具体而言，肠道微生物群的这种调节以IL-11-依赖性方式抑制mmu_circ_0000730表达。生物信息学分析与萤光素酶报告基因分析相结合揭示了mmu_circ_0000730和mmu-miR-466i-3p之间的相互抑制。我们进一步表明，mmu-miR-466i-3p和mmu-miR-466f-3p均抑制许多与上皮间质转化（EMT）和癌症干细胞如SOX9干细胞有关的基因。结论：这些结果提供了以前未认识到的非编码RNA在微生物群介导的癌症转移中的调控作用的证据，因此，微生物组可作为治疗靶标。</p>

<h2>Pubmed_ID: 32684075</h2>

<h3>Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients</h3>

<h3>酒精性肝炎患者粪便细菌群的变化与疾病严重程度的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785251</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32684075/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background and aims: Alcoholic hepatitis is the most severe form of alcohol-related liver disease. While the gut microbiome is known to play a role in disease development and progression, less is known about specific compositional changes of the gut bacterial microbiome associated with disease severity. Therefore, the aim of our study was to correlate gut microbiota features with disease severity in alcoholic hepatitis patients. Methods: We used 16S rRNA gene sequencing on fecal samples from 74 alcoholic hepatitis patients, which were enrolled at 9 centers in Europe, the United States, and Mexico in a multi-center observational study. The relative abundance of gut bacterial taxa on genus level, as well as the microbiome diversity, was correlated to various clinical, laboratory, and histologic parameters. Results: We observed a negative correlation between the model for end-stage liver disease score and Shannon diversity, independent of potentially confounding factors (Padjust = 0.046). Alcoholic hepatitis patients with more severe disease had significantly decreased relative abundances of Akkermansia while the relative abundance of Veillonella was increased. We observed a reduction in the Bacteroides abundance (Padjust = 0.048) and Shannon diversity (Padjust = 0.018) in antibiotic-treated patients and patients receiving steroids had an increase in Veillonella abundance (Padjust = 0.005), which was both independent of potentially confounding factors. Conclusion: We observed distinct changes in the gut bacterial microbiome of alcoholic hepatitis patients with more severe disease. The gut bacterial microbiome might be an attractive target to prevent and treat this deadly disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景与目的：酒精性肝炎是酒精相关性肝病的最严重形式。虽然已知肠道微生物组在疾病的发展和进程中起作用，但对肠道细菌微生物组与疾病严重程度相关的特定组成变化的了解却很少。因此，我们研究的目的是使酒精性肝炎患者的肠道菌群特征与疾病严重程度相关联。方法：我们对来自74个酒精性肝炎患者的粪便样本进行了16SrRNA基因测序，这些样本在欧洲，美国和墨西哥的9个中心进行了多中心观察性研究。肠道菌群在属水平上的相对丰度以及微生物组的多样性与各种临床，实验室和组织学参数相关。结果：我们观察到终末期肝病评分模型与香农多样性之间呈负相关，而与潜在的混杂因素无关（Padjust=0.046）。酒精中毒和重症的肝炎患者阿克曼病的相对丰度显着下降，而维永氏菌的相对丰度则升高。我们观察到抗生素治疗的患者中拟杆菌的丰度（Padjust=0.048）和香农多样性（Padjust=0.018）降低，接受类固醇的患者Veillonella丰度有所增加（Padjust=0.005），这两者均与潜在的混杂因素无关。结论：我们观察到酒精性肝炎病情较重的患者肠道细菌微生物组发生了明显变化。肠道细菌微生物组可能是预防和治疗这种致命疾病的诱人靶标。</p>

<h2>Pubmed_ID: 32663105</h2>

<h3>Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer</h3>

<h3>加塞氏乳杆菌505和a木叶片提取物的合生元组合对结肠炎相关的大肠癌的抗癌作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785803</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32663105/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Previously, a synbiotic combination of probiotic Lactobacillus gasseri 505 (LG) and a new prebiotic, Cudrania tricuspidata leaf extract (CT) in fermented milk, designated FCT, showed an in vitro immunomodulatory effect and antioxidant activity. Although synbiotic combination might have cancer-protective effects, these activities have not been fully validated in vivo. Ten-week treatment of LG, CT, or FCT to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated colorectal cancer (CAC) mouse model reduced both the incidence of colonic tumors and damage to the colonic mucosa effectively, suggesting a cancer-protective effect. To understand these, biomarkers associated with inflammation, colon barrier, apoptosis, and cancer cell proliferation were monitored in AOM/DSS group versus LG/CT/FCT groups. A synbiotic combination (FCT) down-regulated pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1β, and IL-6) and inflammation-associated enzymes (iNOS and COX-2), and up-regulated anti-inflammatory cytokines (IL-4 and IL-10). In addition, colon barrier experiment revealed that biomarkers of mucus layer (MUC-2 and TFF3) and tight junction (occludin and ZO-1) were up-regulated. Subsequent apoptosis experiment showed that pro-apoptotic factors (p53, p21, and Bax) were up-regulated and anti-apoptotic factors (Bcl-2 and Bcl-xL) were down-regulated. Furthermore, comparative metagenome analysis of gut microbiota revealed that Staphylococcus decreased but Lactobacillus, Bifidobacterium, and Akkermansia increased, supporting their protective effects, accompanied by increased short-chain fatty acids (SCFAs). Taken together, the FCT administration showed cancer-protective effects by reducing the risk of colitis-associated colon cancer via regulation of inflammation, carcinogenesis, and compositional change of gut microbiota. Consequently, the synbiotic combination (FCT) could be a novel potential health-protective natural agent against CAC.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 以前，益生菌格氏乳杆菌505（LG）和新型益生元，即发酵乳中的Cudraniatricuspidata叶提取物（CT）的合生素组合显示为FCT，具有体外免疫调节作用和抗氧化活性。尽管合生元组合可能具有抗癌作用，但这些活性尚未在体内得到充分验证。LG，CT或FCT对乙氧基甲烷（AOM）/右旋糖酐硫酸钠（DSS）诱导的结肠炎相关结直肠癌（CAC）小鼠模型进行的十周治疗有效地降低了结肠肿瘤的发生率和对结肠粘膜的损害，提示有保护癌症的作用。为了理解这些，在AOM/DSS组与LG/CT/FCT组中监测了与炎症，结肠屏障，凋亡和癌细胞增殖相关的生物标志物。合生元组合（FCT）下调促炎性细胞因子（TNF-α，IFN-γ，IL-1β和IL-6）和炎症相关酶（iNOS和COX-2），并上调抗-炎性细胞因子（IL-4和IL-10）。此外，结肠屏障实验显示粘液层（MUC-2和TFF3）和紧密连接（occludin和ZO-1）的生物标志物被上调。随后的凋亡实验表明，促凋亡因子（p53，p21和Bax）被上调，而抗凋亡因子（Bcl-2和Bcl-xL）被下调。此外，肠道菌群的比较基因组分析表明，葡萄球菌减少，而乳酸杆菌，双歧杆菌和阿克曼菌增加，支持它们的保护作用，同时增加短链脂肪酸（SCFA）。综上所述，FCT给药通过调节炎症，致癌作用和肠道菌群组成来降低结肠炎相关结肠癌的风险，从而显示出癌症保护作用。因此，合生元组合（FCT）可能是针对CAC的新型潜在健康保护天然药物。</p>

<h2>Pubmed_ID: 32663059</h2>

<h3>The gut microbiome stability is altered by probiotic ingestion and improved by the continuous supplementation of galactooligosaccharide</h3>

<h3>益生菌摄入会改变肠道微生物组的稳定性，而不断补充低聚半乳糖会改善肠道微生物组的稳定性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785252</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32663059/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The stable gut microbiome plays a key role in sustaining host health, while the instability of gut microbiome also has been found to be a risk factor of various metabolic diseases. At the ecological and evolutionary scales, the inevitable competition between the ingested probiotic and indigenous gut microbiome can lead to an increase in the instability. It remains largely unclear if and how exogenous prebiotic can improve the overall gut microbiome stability in probiotic consumption. In this study, we used Lactobacillus plantarum HNU082 (Lp082) as a model probiotic to examine the impact of the continuous or pulsed supplementation of galactooligosaccharide (GOS) on the gut microbiome stability in mice using shotgun metagenomic sequencing. Only continuous GOS supplement promoted the growth of probiotic and decreased its single-nucleotide polymorphisms (SNPs) mutation under competitive conditions. Besides, persistent GOS supplementation increased the overall stability, reshaped the probiotic competitive interactions with Bacteroides species in the indigenous microbiome, which was also evident by over-abundance of carbohydrate-active enzymes (CAZymes) accordingly. Also, we identified a total of 793 SNPs arisen in probiotic administration in the indigenous microbiome. Over 90% of them derived from Bacteroides species, which involved genes encoding transposase, CAZymes, and membrane proteins. However, neither GOS supplementation here de-escalated the overall adaptive mutations within the indigenous microbes during probiotic intake. Collectively, our study demonstrated the beneficial effect of continuous prebiotic supplementation on the ecological and genetic stability of gut microbiomes.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 稳定的肠道微生物组在维持宿主健康中起着关键作用，而肠道微生物组的不稳定性也被认为是各种代谢疾病的危险因素。在生态和进化尺度上，摄入的益生菌和本地肠道微生物组之间不可避免的竞争会导致不稳定性的增加。在益生菌消费中，外源益生元是否以及如何改善肠道整体微生物组的稳定性尚不清楚。在这项研究中，我们使用植物乳杆菌HNU082（Lp082）作为模型益生菌，使用shot弹枪宏基因组测序研究了连续或脉冲补充低聚半乳糖（GOS）对小鼠肠道微生物组稳定性的影响。在竞争条件下，只有连续的GOS补充剂才能促进益生菌的生长并降低其单核苷酸多态性（SNPs）突变。此外，持续补充GOS可以提高整体稳定性，重塑益生菌与本地微生物组中拟杆菌属的竞争性相互作用，这也相应地表现为碳水化合物活性酶（CAZymes）过量。此外，我们确定了在土著微生物组中益生菌给药中产生的总共793个SNP。其中超过90％来自拟杆菌属，其中涉及编码转座酶，CAZymes和膜蛋白的基因。然而，在益生菌摄入过程中，此处的两种GOS补充均未降低土著微生物内部的总体适应性突变。总的来说，我们的研究证明了连续补充益生元对肠道微生物群生态和遗传稳定性的有益作用。</p>

<h2>Pubmed_ID: 32658601</h2>

<h3>Extremely preterm neonates have more Lactobacillus in meconium than very preterm neonates - the in utero microbial colonization hypothesis</h3>

<h3>极早产儿在胎粪中的乳杆菌比极早产儿多-子宫内微生物定植假说</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785804</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32658601/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Growing evidence suggests that maternal microbiota can influence the neonates' gut colonization. However, the mechanisms of vertical bacterial transmission remain poorly defined. We believed that the first colonizers of the newborn come from the mother's gut and vagina during pregnancy and that this is independent of the mode of delivery. We conducted an observational longitudinal study to evaluate the link between the maternal gut microbiota and the meconium's microbiota in extremely and very preterm neonates. Bacterial DNA was extracted from samples and specific bacterial groups were quantified by RT-PCR. In this cohort of 117 preterm neonates, we detected bacterial DNA in 88% of meconium samples. Meconium microbiota of neonates born after 28 gestational weeks (very preterm neonates) showed stronger correlations with their mothers' fecal microbiota. However, neonates born before 28 gestational weeks (extremely preterm neonates) had more Lactobacillus - genus that dominated the vaginal microbiota - than very preterm neonates, regardless of the mode of delivery. Collectively, these data support the hypothesis that maternal bacteria from the gut and vagina can play a role in shaping neonates' gut microbiota and that mother-to-infant bacterial transmission is a controlled and time-specific process. ClinicalTrials.gov Identifier: NCT03663556.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明，母体微生物群会影响新生儿的肠道定植。但是，垂直细菌传播的机制仍然不清楚。我们认为，新生儿的第一个定居者在怀孕期间来自母亲的肠道和阴道，这与分娩方式无关。我们进行了一项观察性纵向研究，以评估极早产儿的肠道菌群和胎粪菌群之间的联系。从样品中提取细菌DNA，并通过RT-PCR定量特定细菌群。在这117个早产儿队列中，我们在88％的胎粪样本中检测到细菌DNA。妊娠28周后出生的新生儿胎粪微生物群（非常早产儿）与母亲的粪便微生物群相关性更强。但是，无论分娩方式如何，在妊娠28周之前出生的新生儿（极早产儿）比绝大多数早产儿具有更多的乳杆菌（占阴道菌群的属）。总的来说，这些数据支持以下假设：来自肠道和阴道的母体细菌可以在塑造新生儿的肠道菌群中发挥作用，而母婴细菌的传播是一个受控制且特定于时间的过程。ClinicalTrials.gov标识符：NCT03663556。</p>

<h2>Pubmed_ID: 32618494</h2>

<h3>Hemolysin BL from novel Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo</h3>

<h3>来自新型芽孢杆菌BV-17的溶血素BL在体外和体内均可诱导抗肿瘤活性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782158</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32618494/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiota plays an important role in cancer development and immunotherapy. Bacterial toxins have enormous antitumor potential due to their cytotoxicity and ability to activate the immune system. Using 16S rRNA gene sequencing, we compared the gut microbiota composition of fecal samples from healthy individuals and patients with colorectal cancer (CRC) and observed that the genus Bacillus was common in the healthy donors but was absent in the CRC patients. Further, we isolated a novel Bacillus toyonensis BV-17 from the fecal samples of the healthy individuals. Our results showed that the supernatant of the Bacillus toyonensis BV-17 cultures could quickly kill various tumor cell lines within minutes in vitro, by causing cell membrane disruption, blebbing, and leakage of cytoplasmic content. Fast protein liquid chromatography (FPLC) and mass spectrometry analysis identified hemolysin BL (HBL) as the effector molecule, which exhibits a different cytotoxicity mechanism compared to previous studies. Intra-tumor injection of low dose HBL inhibited the growth of both treated and untreated tumors in mice. The outcomes of this pioneer study suggest that HBL exhibits antitumor activity and is a potential chemotherapeutic agent that could be engineered to target only tumor cells in future.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群在癌症发展和免疫治疗中起着重要作用。细菌毒素具有细胞毒性和激活免疫系统的能力，因此具有巨大的抗肿瘤潜力。使用16SrRNA基因测序，我们比较了健康人和结直肠癌（CRC）患者粪便样品的肠道菌群组成，并观察到芽孢杆菌属在健康供体中很常见，但在CRC患者中却不存在。此外，我们从健康个体的粪便样品中分离了一种新型的芽孢杆菌芽孢杆菌BV-17。我们的结果表明，Toonensis芽孢杆菌BV-17培养物的上清液可在体外在几分钟内迅速杀死各种肿瘤细胞系，从而引起细胞膜破裂，起泡和细胞质内容物泄漏。快速蛋白液相色谱（FPLC）和质谱分析确定溶血素BL（HBL）是效应分子，与以前的研究相比，其表现出不同的细胞毒性机制。肿瘤内低剂量HBL的注射抑制小鼠中已治疗和未治疗肿瘤的生长。这项先驱研究的结果表明，HBL具有抗肿瘤活性，并且是一种潜在的化学治疗剂，将来可以被设计成仅靶向肿瘤细胞。</p>

<h2>Pubmed_ID: 32615913</h2>

<h3>Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity</h3>

<h3>酒精使用障碍的纵向肠道微生物组变化受节制和饮酒量影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1758010</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32615913/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Many patients with alcohol use disorder (AUD) consume alcohol chronically and in large amounts that alter intestinal microbiota, damage the gastrointestinal tract, and thereby injure other organs via malabsorption and intestinal inflammation. We hypothesized that alcohol consumption and subsequent abstinence would change the gut microbiome in adults admitted to a treatment program. Stool and oral specimens, diet data, gastrointestinal assessment scores, anxiety, depression measures and drinking amounts were collected longitudinally for up to 4 weeks in 22 newly abstinent inpatients with AUD who were dichotomized as less heavy drinkers (LHD, <10 drinks/d) and very heavy drinkers (VHD, 10 or more drinks/d). Next-generation 16 S rRNA gene sequencing was performed to measure the gut and oral microbiome at up to ten time points/subject and LHD and VHD were compared for change in principal components, Shannon diversity index and specific genera. The first three principal components explained 46.7% of the variance in gut microbiome diversity across time and all study subjects, indicating the change in gut microbiome following abstinence. The first time point was an outlier in three-dimensional principal component space versus all other time points. The gut microbiota in LHD and VHD were significantly dissimilar in change from day 1 to day 5 (p = .03) and from day 1 to week 3 (p = .02). The VHD drinking group displayed greater change from baseline. The Shannon diversity index of the gut microbiome changed significantly during abstinence in five participants. In both groups, the Shannon diversity was lower in the oral microbiome than gut. Ten total genera were shared between oral and stool in the AUD participants. These data were compared with healthy controls from the Human Microbiome Project to investigate the concept of a core microbiome. Rapid changes in gut microbiome following abstinence from alcohol suggest resilience of the gut microbiome in AUD and reflects the benefits of refraining from the highest levels of alcohol and potential benefits of abstinence.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 许多患有酒精使用障碍（AUD）的患者长期大量饮酒，这会改变肠道菌群，损害胃肠道，从而通过吸收不良和肠道炎症伤害其他器官。我们假设饮酒和随后的戒酒会改变接受治疗方案的成年人的肠道微生物组。纵向收集了22名刚戒断的AUD住院患者的粪便和口腔标本，饮食数据，胃肠道评估评分，焦虑，抑郁量度和饮酒量，长达4周，这些患者被分为轻度饮酒者（LHD，<10杯/天）和非常沉重的饮酒者（VHD，每天喝10杯或更多）。进行了下一代16SrRNA基因测序，以测量肠道和口腔微生物组的最高时间点为十个时间点，并比较了LHD和VHD的主要成分，香农多样性指数和特定属的变化。前三个主要成分解释了整个时间段和所有研究对象的肠道微生物组多样性的46.7％的变化，表明禁欲后肠道微生物组的变化。第一个时间点是三维主成分空间与所有其他时间点的异常值。从第1天到第5天（p=.03）和从第1天到第3周（p=.02），LHD和VHD中的肠道菌群变化明显不同。VHD饮酒组与基线相比显示出更大的变化。在禁欲期间，五名参与者的肠道微生物组的香农多样性指数发生了显着变化。在两组中，口腔微生物组的香农多样性均低于肠道。AUD参加者的口腔和粪便共有10个属。将这些数据与人类微生物组计划的健康对照进行比较，以研究核心微生物组的概念。戒酒后肠道微生物组的快速变化表明肠道微生物组在AUD中具有弹性，并反映了戒除酒精含量最高的好处和戒酒的潜在好处。</p>

<h2>Pubmed_ID: 32588725</h2>

<h3>Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans</h3>

<h3>肠道通透性，微生物移位，十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782157</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32588725/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Animal data suggest a role of the gut-liver axis in progression of alcoholic liver disease (ALD), but human data are scarce especially for early disease stages. Methods: We included patients with alcohol use disorder (AUD) who follow a rehabilitation program and matched healthy controls. We determined intestinal epithelial and vascular permeability (IP) (using urinary excretion of 51Cr-EDTA, fecal albumin content, and immunohistochemistry in distal duodenal biopsies), epithelial damage (histology, serum iFABP, and intestinal gene expression), and microbial translocation (Gram - and Gram + serum markers by ELISA). Duodenal mucosa-associated microbiota and fecal microbiota were analyzed by 16 S rRNA sequencing. ALD was staged by Fibroscan® (liver stiffness, controlled attenuation parameter) in combination with serum AST, ALT, and CK18-M65. Results: Only a subset of AUD patients had increased 51Cr-EDTA and fecal albumin together with disrupted tight junctions and vasculature expression of plasmalemma Vesicle-Associated Protein-1. The so-defined increased intestinal permeability was not related to changes of the duodenal microbiota or alterations of the intestinal epithelium but associated with compositional changes of the fecal microbiota. Leaky gut alone did not explain increased microbial translocation in AUD patients. By contrast, duodenal dysbiosis with a dominance shift toward specific potential pathogenic bacteria genera (Streptococcus, Shuttleworthia, Rothia), increased IP and elevated markers of microbial translocation characterized AUD patients with progressive ALD (steato-hepatitis, steato-fibrosis). Conclusion: Progressive ALD already at early disease stages is associated with duodenal mucosa-associated dysbiosis and elevated microbial translocation. Surprisingly, such modifications were not linked with increased IP. Rather, increased IP appears related to fecal microbiota dysbiosis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：动物数据表明，肠肝轴在酒精性肝病（ALD）的进展中起着重要作用，但人类数据稀少，尤其是在疾病早期。方法：我们纳入了遵循康复计划并与健康对照匹配的酒精滥用障碍（AUD）患者。我们确定了肠上皮和血管通透性（IP）（使用51Cr-EDTA的尿液排泄，粪便白蛋白含量和十二指肠远端活检的免疫组化），上皮损伤（组织学，血清iFABP和肠基因表达）以及微生物移位（Gram-和革兰氏+血清标记（通过ELISA）。通过16SrRNA测序分析十二指肠粘膜相关菌群和粪便菌群。通过Fibroscan®（肝硬度，可控制的衰减参数）与血清AST，ALT和CK18-M65联合进行ALD分级。结果：只有一部分AUD患者的51Cr-EDTA和粪便白蛋白增加，血浆膜囊泡相关蛋白1的紧密连接和脉管系统表达受损。如此增加的肠通透性与十二指肠微生物群的改变或肠上皮的改变无关，而与粪便微生物群的组成改变有关。肠道泄漏本身并不能解释AUD患者微生物易位的增加。相比之下，十二指肠营养不良的优势转向特定的潜在病原细菌属（链球菌，Shuttleworthia，Rothia），IP增高和微生物易位标记升高，这些特征使AUD患者进行性ALD（脂肪性肝炎，脂肪性纤维化）。结论：已经在疾病早期进行的渐进性ALD与十二指肠粘膜相关性营养不良和微生物易位相关。令人惊讶的是，此类修改与IP的增加没有关联。相反，IP增加似乎与粪便微生物群失调有关。</p>

<h2>Pubmed_ID: 32586195</h2>

<h3>The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli</h3>

<h3>自身免疫敏感性基因PTPN2限制新型小鼠黏附侵入性大肠杆菌的扩增</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1775538</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32586195/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Inflammatory bowel disease (IBD) pathogenesis involves significant contributions from genetic and environmental factors. Loss-of-function single-nucleotide polymorphisms (SNPs) in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene increase IBD risk and are associated with altered microbiome population dynamics in IBD. Expansion of intestinal pathobionts, such as adherent-invasive E. coli (AIEC), is strongly implicated in IBD pathogenesis as AIEC increases pro-inflammatory cytokine production and alters tight junction protein regulation - suggesting a potential mechanism of pathogen-induced barrier dysfunction and inflammation. We aimed to determine if PTPN2 deficiency alters intestinal microbiome composition to promote expansion of specific bacteria with pathogenic properties. In mice constitutively lacking Ptpn2, we identified increased abundance of a novel mouse AIEC (mAIEC) that showed similar adherence and invasion of intestinal epithelial cells, but greater survival in macrophages, to the IBD-associated AIEC, LF82. Furthermore, mAIEC caused disease when administered to mice lacking segmented-filamentous bacteria (SFB), and in germ-free mice but only when reconstituted with a microbiome, thus supporting its classification as a pathobiont, not a pathogen. Moreover, mAIEC infection increased the severity of, and prevented recovery from, induced colitis. Although mAIEC genome sequence analysis showed >90% similarity to LF82, mAIEC contained putative virulence genes with >50% difference in gene/protein identities from LF82 indicating potentially distinct genetic features of mAIEC. We show for the first time that an IBD susceptibility gene, PTPN2, modulates the gut microbiome to protect against a novel pathobiont. This study generates new insights into gene-environment-microbiome interactions in IBD and identifies a new model to study AIEC-host interactions.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 炎症性肠病（IBD）发病机理涉及遗传和环境因素的重大贡献。蛋白酪氨酸磷酸酶非受体2型（PTPN2）基因的功能丧失单核苷酸多态性（SNP）增加IBD风险，并与IBD中微生物组种群动态变化有关。肠病原生物的扩张，例如黏附侵入性大肠杆菌（AIEC），与IBD发病机理密切相关，因为AIEC增加了促炎性细胞因子的产生并改变了紧密连接蛋白的调节-表明病原体诱导的屏障功能障碍和炎症的潜在机制。我们旨在确定PTPN2缺乏症是否会改变肠道微生物组组成，以促进具有致病特性的特定细菌的扩增。在组成型缺乏Ptpn2的小鼠中，我们发现与IBD相关的AIEC，LF82相比，新型小鼠AIEC（mAIEC）的丰度增加，该AIEC显示出与肠上皮细胞相似的粘附和侵袭，但在巨噬细胞中的存活率更高。此外，当对缺乏节段性丝状细菌（SFB）的小鼠和无细菌的小鼠给药时，mAIEC会引起疾病，但仅在用微生物组重组时才起作用，因此支持将其分类为病原体，而不是病原体。而且，mAIEC感染增加了诱发性结肠炎的严重性并阻止了其恢复。尽管mAIEC基因组序列分析显示与LF82的相似性>90％，但mAIEC包含推定的毒力基因，与LF82的基因/蛋白质同一性差异>50％，表明mAIEC可能具有明显的遗传特征。我们首次表明，IBD易感基因PTPN2调节肠道微生物组，以防御新型病原菌。这项研究对IBD中的基因-环境-微生物组相互作用产生了新的见解，并确定了研究AIEC-宿主相互作用的新模型。</p>

<h2>Pubmed_ID: 32584650</h2>

<h3>Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation</h3>

<h3>长双歧杆菌通过Paneth细胞调节减轻肠易激综合征相关的内脏超敏反应和微生物群失调</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782156</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584650/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell function. We confirmed the beneficial effects of B. longum on defecation habits and visceral hypersensitivity in WAS rats. Further analysis revealed that B. longum enhanced mucosal repair, promoted lysozyme production, and ameliorated dysbiosis of the microbiota in WAS rats. These processes are closely correlated with Paneth cell functions. In vitro, we incubated primary cultured enteroids with B. longum and found that B. longum promoted the proliferation of these organoids; this may be attributed to the upregulation of the stem niche factors WNT3A and TGF-β, which are secreted by Paneth cells. Based on our findings, we propose that B. longum relieves IBS by restoring the antimicrobial activity and stem niche maintenance function of Paneth cells.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管口服双歧杆菌（长双歧杆菌）可缓解临床环境中肠易激综合症（IBS）的症状，但其作用机理尚不清楚。在这项研究中，我们通过调节Paneth细胞功能评估了长双歧杆菌对IBS的精确作用。我们证实了长双歧杆菌对WAS大鼠排便习惯和内脏超敏反应的有益作用。进一步的分析表明，长双歧杆菌增强了粘膜修复，促进了溶菌酶的产生，并改善了WAS大鼠中微生物群的营养不良。这些过程与Paneth细胞功能密切相关。在体外，我们用长双歧杆菌孵育初次培养的类肠素，发现长双歧杆菌可促进这些类器官的增殖。这可能归因于Paneth细胞分泌的干生态位因子WNT3A和TGF-β的上调。根据我们的发现，我们建议长双歧杆菌通过恢复Paneth细胞的抗菌活性和干生位维持功能来缓解IBS。</p>

<h2>Pubmed_ID: 32584649</h2>

<h3>Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis</h3>

<h3>肽酶PepP是空肠弯曲菌的新型致病因子，可导致鼠类弯曲杆菌病</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770017</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584649/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Mechanisms of host-pathogen interactions resulting in immunopathological responses upon human Campylobacter jejuni infection are not completely understood, but the recent availability of murine infection models mimicking key features of campylobacteriosis helps solving this dilemma. During a screen for proteases expressed by C. jejuni, we identified a peptidase of the M24 family as a potential novel virulence factor, which was named PepP. The gene is strongly conserved in various Campylobacter species. A constructed deletion mutant ΔpepP of C. jejuni strain 81-176 grew as efficiently compared to isogenic wild-type (WT) or pepP complemented bacteria. To shed light on the potential role of this protease in mediating immunopathological responses in the mammalian host, we perorally challenged microbiota-depleted IL-10-/- mice with these strains. All strains stably colonized the murine gastrointestinal tract with comparably high loads. Remarkably, pepP deficiency was associated with less severe induced malaise, with less distinct apoptotic and innate immune cell responses, but also with more pronounced proliferative/regenerative epithelial cell responses in the large intestine at d6post-infection. Furthermore, pro-inflammatory mediators were lower in the colon, ileum, and mesenteric lymph nodes of mice that had been challenged with the ΔpepP mutant compared to the WT or pepP complemented strains. This also held true for extra-intestinal organs including liver, kidneys, and lungs, and, strikingly, to systemic compartments. Taken together, protease PepP is a novel virulence determinant involved in mediating campylobacteriosis. The finding that apoptosis in the colon is significantly diminished in mice infected with the pepP mutant highlights the epithelial layer as the first and main target of PepP in the intestine.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 宿主-病原体相互作用的机制导致对人空肠弯曲菌感染的免疫病理反应尚不完全清楚，但是模仿弯曲菌的关键特征的鼠类感染模型的最新可用性有助于解决这一难题。在筛选空肠弯曲杆菌表达的蛋白酶的过程中，我们鉴定了M24家族的肽酶作为一种潜在的新型毒力因子，称为PepP。该基因在各种弯曲杆菌属中高度保守。与同基因野生型（WT）或pepP互补细菌相比，空肠弯曲杆菌81-176的构建缺失突变ΔpepP的生长效率很高。为了阐明这种蛋白酶在介导哺乳动物宿主中免疫病理反应中的潜在作用，我们用这些菌株经口挑战了耗竭了微生物的IL-10-/-小鼠。所有菌株均以较高的负荷稳定地定居在鼠的胃肠道中。值得注意的是，pepP缺乏与较少严重的诱发不适，较少的凋亡和先天免疫细胞反应有关，也与感染后d6大肠中较明显的增殖/再生上皮细胞反应有关。此外，与WT或pepP互补菌株相比，用ΔpepP突变体攻击的小鼠的结肠，回肠和肠系膜淋巴结中的促炎性介质较低。对于包括肝，肾和肺在内的肠外器官，尤其是全身性隔室，也是如此。两者合计，蛋白酶PepP是一种新型的介导弯曲杆菌病的毒力决定因素。在被pepP突变体感染的小鼠中，结肠细胞凋亡显着减少的发现凸显出上皮层是肠道中PepP的第一个也是主要靶标。</p>

<h2>Pubmed_ID: 32584645</h2>

<h3>Life-long dynamics of the swine gut microbiome and their implications in probiotics development and food safety</h3>

<h3>猪肠道微生物组的终生动力学及其对益生菌发展和食品安全的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1773748</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584645/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The swine gut microbiome has received remarkable attention in recent years given that pigs serve not only as important sources for animal-derived food but also as excellent biomedical models for human health. However, despite recent advances in the understanding of the swine gut microbiome, many important biological and ecological questions are still largely unanswered. In a recent study, we characterized the life-long dynamics of the swine gut microbiome from birth to market. We showed distinct shifts in gut microbiome structure along different growth stages mainly driven by diet. Here, we summarize these discoveries and provide additional data related to the core swine gut microbiome, probiotics development in the swine industry, and foodborne pathogens in the pork supply chain.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 近年来，猪肠道微生物组受到了广泛关注，因为猪不仅是动物源食品的重要来源，而且还是人类健康的出色生物医学模型。然而，尽管最近对猪肠道微生物组的理解有了进步，但许多重要的生物学和生态学问题仍未得到解答。在最近的一项研究中，我们描述了从出生到上市的猪肠道微生物组的终生动力学。我们显示了肠道微生物组结构在不同生长阶段的明显变化，这些变化主要受饮食驱动。在这里，我们总结这些发现，并提供与核心猪肠道微生物组，养猪业中益生菌的发展以及猪肉供应链中食源性病原体有关的其他数据。</p>

<h2>Pubmed_ID: 32579470</h2>

<h3>Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice</h3>

<h3>无病菌的居住条件不会影响晚期动脉粥样硬化低密度脂蛋白受体缺陷型小鼠的主动脉根和主动脉弓病变大小</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1767463</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32579470/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The microbiota has been linked to the development of atherosclerosis, but the functional impact of these resident bacteria on the lesion size and cellular composition of atherosclerotic plaques in the aorta has never been experimentally addressed with the germ-free low-density lipoprotein receptor-deficient (Ldlr-/- ) mouse atherosclerosis model. Here, we report that 16 weeks of high-fat diet (HFD) feeding of hypercholesterolemic Ldlr-/- mice at germ-free (GF) housing conditions did not impact relative aortic root plaque size, macrophage content, and necrotic core area. Likewise, we did not find changes in the relative aortic arch lesion size. However, late atherosclerotic GF Ldlr-/- mice had altered inflammatory plasma protein markers and reduced smooth muscle cell content in their atherosclerotic root plaques relative to CONV-R Ldlr-/- mice. Neither absolute nor relative aortic root or aortic arch plaque size correlated with age. Our analyses on GF Ldlr-/- mice did not reveal a significant contribution of the microbiota in late aortic atherosclerosis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 微生物群与动脉粥样硬化的发展有关，但是这些常驻细菌对主动脉中动脉粥样硬化斑块的病变大小和细胞组成的功能影响从未通过无细菌的低密度脂蛋白受体缺陷实验来解决（Ldlr-/-）小鼠动脉粥样硬化模型。在这里，我们报告在无菌（GF）居住条件下高胆固醇饮食Ldlr-/-小鼠高脂饮食（HFD）喂养16周不会影响相对主动脉根斑块大小，巨噬细胞含量和坏死核心面积。同样，我们也没有发现主动脉弓相对病变大小的变化。然而，相对于CONV-RLdlr-/-小鼠，晚期动脉粥样硬化GFLdlr-/-小鼠改变了炎症血浆蛋白标志物并降低了其动脉粥样硬化根斑中的平滑肌细胞含量。绝对主动脉根或相对主动脉根或主动脉弓斑的大小均与年龄无关。我们对GFLdlr-/-小鼠的分析未揭示微生物群在晚期主动脉粥样硬化中的重要作用。</p>

<h2>Pubmed_ID: 32576065</h2>

<h3>Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes</h3>

<h3>反映肠道微生物组α多样性的血清代谢物可预测2型糖尿病</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1778261</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32576065/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Type 2 diabetes (T2D) is associated with reduced gut microbiome diversity, although the cause is unclear. Metabolites generated by gut microbes also appear to be causative factors in T2D. We therefore searched for serum metabolites predictive of gut microbiome diversity in 1018 females from TwinsUK with concurrent metabolomic profiling and microbiome composition. We generated a Microbial Metabolites Diversity (MMD) score of six circulating metabolites that explained over 18% of the variance in microbiome alpha diversity. Moreover, the MMD score was associated with a significantly lower odds of prevalent (OR[95%CI] = 0.22[0.07;0.70], P = .01) and incident T2D (HR[95%CI] = 0.31[0.11,0.90], P = .03). We replicated our results in 1522 individuals from the ARIC study (prevalent T2D: OR[95%CI] = 0.79[0.64,0.96], P = .02, incident T2D: HR[95%CI] = 0.87[0.79,0.95], P = .003). The MMD score mediated 28%[15%,94%] of the total effect of gut microbiome on T2D after adjusting for confounders. Metabolites predicting higher microbiome diversity included 3-phenylpropionate(hydrocinnamate), indolepropionate, cinnamoylglycine and 5-alpha-pregnan-3beta,20 alpha-diol monosulfate(2) of which indolepropionate and phenylpropionate have already been linked to lower incidence of T2D. Metabolites correlating with lower microbial diversity included glutarate and imidazole propionate, of which the latter has been implicated in insulin resistance. Our results suggest that the effect of gut microbiome diversity on T2D is largely mediated by microbial metabolites, which might be modifiable by diet.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管病因尚不清楚，但2型糖尿病（T2D）与肠道微生物组多样性降低有关。肠道微生物产生的代谢产物似乎也是T2D的致病因素。因此，我们从TwinsUK中搜索可预测1018位女性肠道微生物组多样性的血清代谢物，同时进行代谢组学分析和微生物组组成分析。我们生成了六个循环代谢物的微生物代谢物多样性（MMD）评分，这解释了微生物组alpha多样性中超过18％的差异。此外，MMD评分与患病率（OR[95％CI]=0.22[0.07;0.70]，P=.01）和入射T2D（HR[95％CI]=0.31[0.11,0.90]]，P=.03）。我们在ARIC研究中的1522个人中复制了我们的结果（流行的T2D：OR[95％CI]=0.79[0.64,0.96]，P=.02，事件T2D：HR[95％CI]=0.87[0.79,0.95]，P=.003）。调整混杂因素后，MMD评分介导了肠道微生物组对T2D的总作用的28％[15％，94％]。预测更高微生物组多样性的代谢物包括3-苯基丙酸酯（氢肉桂酸酯），吲哚丙酸酯，肉桂酰甘氨酸和5-α-pregnan-3beta，20α-二醇单硫酸盐（2），其中吲哚丙酸酯和苯基丙酸酯已与T2D的降低相关。与较低的微生物多样性相关的代谢物包括戊二酸和咪唑丙酸酯，其中后者与胰岛素抵抗有关。我们的结果表明，肠道微生物组多样性对T2D的影响很大程度上是由微生物代谢产物介导的，这可以通过饮食改变。</p>

<h2>Pubmed_ID: 32576050</h2>

<h3>Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice</h3>

<h3>通过改变高脂饮食后代小鼠的肠道菌群和脂质代谢，预防非酒精性脂肪肝疾病的性别特异性母体钙需求</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768645</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32576050/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The significance of maternal appropriate calcium intakes for energy metabolism in the offspring has been recognized. Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of metabolic syndrome. So in this study, we proposed that there were long-term effects of maternal calcium status on the progress of NAFLD by altering the intestinal microbiota and lipid metabolism with attention to potential sex differences among the mouse offspring. Thirty-four-week female C57BL/6 J mice were subjected to obtain low, normal and high calcium reproductive diets throughout the gestation and lactation. After weaning, both the male and female mouse offspring were fed with the high-fat diet for 16 weeks, with the normal diet as control. Biochemical indicators in the plasma and hepatic tissue were measured using ELISA or enzymatic methods. The expression of lipid metabolism, inflammatory and fibrosis related genes was determined by RT-PCR. The intestinal microbiota was analyzed by 16S rRNA high-throughput sequencing. Maternal normal and low calcium intake could, respectively, inhibit the progress of high-fat diet induced NAFLD in the male and female mouse offspring, which was characterized by the least lipid droplets, inflammatory infiltration and fibrosis, the lowest concentrations of free fatty acids and triglyceridethe lowest expression of genes involving in de novo lipogenesis and the highest expression of genes related to lipid oxidation and hydrolysis, inflammatory, and fibrosis. Pyrosequencing of 16S rRNA genes revealed that the male mouse offspring with maternal normal calcium intake and the female mouse offspring with maternal low calcium intake, after the high-fat diet feeding, had distinct intestinal microbiota, which was closer to thosein mice with the normal diet feeding. Analysis of the functional features for the different microbiota was compatible with the expression of genes associated with lipogenesis, lipid oxidation and hydrolysis. Thus, there is a sex-specific manner for maternal calcium requirement to inhibit the progress of offspring NAFLD, that might be less for the female offspring and more for the male offspring.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 人们已经认识到母体适当摄入钙对于后代能量代谢的重要性。非酒精性脂肪肝疾病（NAFLD）被认为是代谢综合征的肝表现。因此，在这项研究中，我们提出母体钙状态对NAFLD的进展具有长期影响，可以通过改变肠道菌群和脂质代谢，并注意小鼠后代之间的性别差异来改善NAFLD的进展。在整个妊娠和哺乳期，对34周的雌性C57BL/6J小鼠进行低，正常和高钙的生殖饮食。断奶后，雄性和雌性小鼠后代均以高脂饮食喂养16周，以正常饮食为对照。使用ELISA或酶法测量血浆和肝组织中的生化指标。通过RT-PCR确定脂质代谢，炎性和纤维化相关基因的表达。通过16SrRNA高通量测序分析肠道菌群。母体正常和低钙摄入分别可以抑制高脂饮食诱导的雄性和雌性小鼠后代的NAFLD的进展，其特征是脂质滴最少，炎症浸润和纤维化最少，游离脂肪酸和甘油三酸酯涉及新生脂肪形成的基因的最低表达，与脂质氧化和水解，炎性和纤维化相关的基因的最高表达。16SrRNA基因的焦磷酸测序表明，高脂饮食喂养后，母体钙摄入量正常的雄性小鼠后代和母体钙摄入量低的雌性小鼠后代具有明显的肠道菌群，与正常饮食的小鼠相近。喂养。分析不同微生物群的功能特征与与脂肪形成，脂质氧化和水解相关的基因表达兼容。因此，母体需要钙来抑制后代NAFLD的发展，这是一种针对性别的方式，对于雌性后代可能较少，而雄性后代则更多。</p>

<h2>Pubmed_ID: 32573326</h2>

<h3>Glycated milk protein fermented with Lactobacillus rhamnosus ameliorates the cognitive health of mice under mild-stress condition</h3>

<h3>鼠李糖乳杆菌发酵的糖化乳蛋白改善了轻度应激条件下小鼠的认知健康</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1756690</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32573326/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: This study aimed to investigate the effects of glycated milk casein (Gc) fermented with Lactobacillus rhamnosus 4B15 (FGc) on the intestinal microbiota and physiological and behavioral properties in mice under chronic stress. Mice were administered Gc or FGc for 10 weeks and then exposed to unpredictable chronic mild stress (UCMS) for 7 weeks. FGc administration restored alterations of gut microbiota induced by UCMS. Moreover, FGc significantly reduced the stress-induced increase in serum corticosterone and decrease in serotonin levels. Anxiety-like behaviors induced by UCMS were also significantly decreased in the FGc group. UCMS-induced dysregulation of gene and protein expression related to neuroendocrine function, neuronal development, and inflammation, and gut-blood-brain barrier function was controlled by FGc pre-treatment. These results strongly suggest the protective effects of FGc targeting of intestinal microbiota for abnormal brain activity, which is consistent with the view that FGc plays an important role in regulating stress-related gut-brain axis disorders.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 这项研究旨在调查鼠李糖乳杆菌4B15（FGc）发酵的糖化酪蛋白（Gc）对慢性应激小鼠肠道菌群以及生理和行为特性的影响。给予小鼠Gc或FGc10周，然后暴露于不可预测的慢性轻度应激（UCMS）7周。FGc施用恢复了UCMS诱导的肠道菌群的改变。此外，FGc显着降低了应激引起的血清皮质酮水平的升高和血清素水平的降低。在FGc组中，UCMS引起的焦虑样行为也明显减少。UCMS诱导的与神经内分泌功能，神经元发育和炎症以及肠血脑屏障功能有关的基因和蛋白质表达失调由FGc预处理控制。这些结果强烈表明，FGc靶向肠道菌群对脑部异常活动具有保护作用，这与以下观点一致：FGc在调节应激相关的肠脑轴疾病中起重要作用。</p>

<h2>Pubmed_ID: 32573321</h2>

<h3>Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production</h3>

<h3>肠杆菌科细菌的定殖通过调节皮质酮的产生对于鼠小肠的急性炎症反应至关重要</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1765946</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32573321/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Although dysbiosis in the gut microbiota is known to be involved in several inflammatory diseases, whether any specific bacterial taxa control host response to inflammatory stimuli is still elusive. Here, we hypothesized that dysbiotic indigenous taxa could be involved in modulating host response to inflammatory triggers. To test this hypothesis, we conducted experiments in germ-free (GF) mice and in mice colonized with dysbiotic taxa identified in conventional (CV) mice subjected to chemotherapy-induced mucositis. First, we report that the absence of microbiota decreased inflammation and damage in the small intestine after administration of the chemotherapeutic agent 5-fluorouracil (5-FU). Also, 5-FU induced a shift in CV microbiota resulting in higher amounts of Enterobacteriaceae, including E. coli, in feces and small intestine and tissue damage. Prevention of Enterobacteriaceae outgrowth by treating mice with ciprofloxacin resulted in diminished 5-FU-induced tissue damage, indicating that this bacterial group is necessary for 5-FU-induced inflammatory response. In addition, monocolonization of germ-free (GF) mice with E. coli led to reversal of the protective phenotype during 5-FU chemotherapy. E. coli monocolonization decreased the basal plasma corticosterone levels and blockade of glucocorticoid receptor in GF mice restored inflammation upon 5-FU treatment. In contrast, treatment of CV mice with ciprofloxacin, that presented reduction of Enterobacteriaceae and E. coli content, induced an increase in corticosterone levels. Altogether, these findings demonstrate that Enterobacteriaceae outgrowth during dysbiosis impacts inflammation and tissue injury in the small intestine. Importantly, indigenous Enterobacteriaceae modulates host production of the anti-inflammatory steroid corticosterone and, consequently, controls inflammatory responsiveness in mice.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管已知肠道菌群中的营养不良与多种炎性疾病有关，但仍然不清楚是否有任何特定的细菌类群控制宿主对炎性刺激的反应。在这里，我们假设营养不良的本地生物分类群可能参与调节宿主对炎症触发的反应。为了验证该假设，我们在无菌（GF）小鼠和在常规（CV）小鼠中接受化疗诱导的粘膜炎鉴定的具有营养不良类群的小鼠中进行了实验。首先，我们报告说，在使用化学治疗剂5-氟尿嘧啶（5-FU）后，微生物群的缺乏降低了小肠的炎症和损害。同样，5-FU引起CV微生物群的转移，导致粪便中肠杆菌科细菌（包括大肠杆菌）的含量增加，并对小肠和组织造成损害。通过用环丙沙星治疗小鼠来预防肠杆菌科细菌的生长，导致减少的5-FU诱导的组织损伤，表明该细菌群对于5-FU诱导的炎症反应是必需的。此外，用大肠杆菌对无菌（GF）小鼠进行单菌落化导致5-FU化疗期间保护性表型的逆转。大肠杆菌的单结肠化降低了GF小鼠的基础血浆皮质类固醇水平，而糖皮质激素受体的阻滞恢复了5-FU治疗后的炎症。相反，用环丙沙星治疗CV小鼠会降低肠杆菌科和大肠杆菌含量，从而导致皮质酮水平升高。总而言之，这些发现表明，在营养不良期间肠杆菌科细菌的生长会影响小肠​​的炎症和组织损伤。重要的是，本地肠杆菌科可调节抗炎类固醇皮质酮的宿主产生，从而控制小鼠的炎症反应。</p>

<h2>Pubmed_ID: 32564657</h2>

<h3>Luminal microbiota related to Crohn's disease recurrence after surgery</h3>

<h3>术后克罗恩氏病复发相关的发光菌群</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1778262</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32564657/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Microbial factors are likely to be involved in the recurrence of Crohn's disease (CD) after bowel resection. We investigated the luminal microbiota before and longitudinally after surgery, in relation to disease recurrence, using 16S metagenomic techniques. Methods: In the prospective Post-Operative Crohn's Endoscopic Recurrence (POCER) study, fecal samples were obtained before surgery and 6, 12, and 18 months after surgery from 130 CD patients. Endoscopy was undertaken to detect disease recurrence, defined as Rutgeerts score ≥i2, at 6 months in two-thirds of patients and all patients at 18 months after surgery. The V2 region of the 16S rRNA gene was sequenced using Illumina MiSeq. Cluster analysis was performed at family level, assessing microbiome community differences between patients with and without recurrence. Results: Six microbial cluster groups were identified. The cluster associated with maintenance of remission was enriched for the Lachnospiraceae family [adjusted OR 0.47 (0.27-0.82), P = .007]. The OTU diversity of Lachnospiraceae within this cluster was significantly greater than in all other clusters. The cluster enriched for Enterobacteriaceae was associated with an increased risk of disease recurrence [adjusted OR 6.35 (1.24-32.44), P = .026]. OTU diversity of Enterobacteriaceae within this cluster was significantly greater than in other clusters. Conclusions: Luminal bacterial communities are associated with protection from, and the occurrence of, Crohn's disease recurrence after surgery. Recurrence may relate to a higher abundance of facultatively anaerobic pathobionts from the Enterobacteriaceae family. The ecologic change of depleted Lachnospiraceae, a genus of butyrate-producing bacteria, may permit expansion of Enterobacteriaceae through luminal environmental perturbation.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：肠道切除后克罗恩病（CD）的复发可能与微生物因素有关。我们使用16S宏基因组学技术研究了手术前后腔内微生物群与疾病复发的关系。方法：在前瞻性术后克罗恩内镜下复发（POCER）研究中，从130名CD患者手术前，手术后6、12和18个月获得粪便样本。在三分之二的患者以及术后18个月的所有患者中，进行了内镜检查以检测疾病复发，定义为Rutgeerts评分≥i2。使用IlluminaMiSeq对16SrRNA基因的V2区进行测序。在家庭层面进行聚类分析，评估有无复发患者之间的微生物组群落差异。结果：确定了六个微生物簇组。与鞭毛科家族相关的集群得以维持[调整OR0.47（0.27-0.82），P=.007]。该簇中的斜鞭草科的OTU多样性显着大于所有其他簇。富含肠杆菌科的菌群与疾病复发的风险增加相关[校正OR6.35（1.24-32.44），P=.026]。肠杆菌科的OTU多样性明显高于其他集群。结论：发光细菌群落与术后克罗恩病复发的保护和发生有关。复发可能与来自肠杆菌科的兼性厌氧菌有较高的关系。枯草杆菌科（一种产生丁酸盐的细菌）的生态变化可能会通过腔内环境扰动使肠杆菌科扩大。</p>

<h2>Pubmed_ID: 32552401</h2>

<h3>Dynamic analysis of human small intestinal microbiota after an ingestion of fermented milk by small-intestinal fluid perfusion using an endoscopic retrograde bowel insertion technique</h3>

<h3>内窥镜逆行肠插入技术通过小肠液体灌流摄入发酵乳后人类小肠微生物群的动态分析</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766942</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552401/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Probiotic products have been shown to have beneficial effects on human hosts, but what happens in the gastrointestinal tract after its ingestion remains unclear. Our aim was to investigate the changes within the small intestines after a single intake of a fermented milk product containing a probiotic. We have periodically collected the small-intestinal fluids from the terminal ileum of seven healthy subjects for up to 7 h after ingestion by small-intestinal fluid perfusion using an endoscopic retrograde bowel insertion technique. The bacterial composition of the terminal ileum clearly revealed that the ingested probiotics (Lactobacillus casei strain Shirota: LcS and Bifidobacterium breve strain Yakult: BbrY) occupied the ileal microbiota for several hours, temporarily representing over 90% of the ileal microbiota in several subjects. Cultivation of ileal fluids showed that under a dramatic pH changes before reaching the terminal ileum, a certain number of the ingested bacteria survived (8.2 ± 6.4% of LcS, 7.8 ± 11.0% of BbrY). This means that more than 1 billion LcS and BbrY cells reached the terminal ileum with their colony-forming ability intact. These results indicate that there is adequate opportunity for the ingested probiotics to continuously stimulate the host cells in the small intestines. Our data suggest that probiotic fermented milk intake affects intestinal microbes and the host, explaining part of the process from the intake of probiotics to the exertion of their beneficial effects on the host.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 益生菌产品已显示对人体宿主具有有益作用，但尚不清楚摄取后在胃肠道中发生的情况。我们的目的是调查单次摄入含有益生菌的发酵乳产品后小肠内的变化。我们采用内窥镜逆行肠插入技术，通过小肠液体灌流，在摄取后长达7小时内，定期收集了7名健康受试者末端回肠的小肠液体。回肠末端的细菌组成清楚地表明，摄入的益生菌（干酪乳杆菌Shirota菌株：LcS和短双歧杆菌Yakult菌株：BbrY）占据了回肠菌群数小时，暂时代表了多个受试者中回肠菌群的90％以上。回肠液的培养表明，在到达末端回肠之前，pH发生了剧烈变化，一定数量的被摄入细菌得以存活（LcS的8.2±6.4％，BbrY的7.8±11.0％）。这意味着超过10亿的LcS和BbrY细胞以完整的集落形成能力到达了回肠末端。这些结果表明，摄入的益生菌有足够的机会连续刺激小肠中的宿主细胞。我们的数据表明，益生菌发酵乳的摄入会影响肠道微生物和宿主，从而解释了从摄入益生菌到对宿主发挥有益作用的过程的一部分。</p>

<h2>Pubmed_ID: 32552337</h2>

<h3>Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation</h3>

<h3>粪便的处理速度和储存时间不影响粪便菌群移植的临床效果</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768777</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552337/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

<h2>Pubmed_ID: 32552224</h2>

<h3>Gut Bacteria have a novel sweet tooth: ribose sensing and scavenging from fiber</h3>

<h3>肠道细菌具有新颖的甜食：核糖感​​测和纤维清除</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770667</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552224/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dietary fiber is known to influence symbiotic gut microbiota community structure and physiology; however, how and if dietary fiber can induce further exogenous nutrient uptake within gut microbes is ill-defined. Recent findings highlight how during periods of high-fiber consumption, a prevalent gut bacteria senses and scavenges the ubiquitous sugar ribose. This molecular adaptation exemplifies how particular gut microbes have developed a sophisticated system to scavenge nutrients in a diet-dependent manner.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 已知膳食纤维会影响共生肠道微生物群的结构和生理。然而，如何以及是否通过膳食纤维诱导肠道微生物进一步吸收外源营养物质还不清楚。最近的发现突显出在高纤维消耗期间，普遍的肠道细菌如何感知并清除普遍存在的糖核糖。这种分子适应性例证了特定的肠道微生物如何开发出复杂的系统以饮食依赖的方式清除营养。</p>

<h2>Pubmed_ID: 32529941</h2>

<h3>The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice</h3>

<h3>肠道菌群和NLRP3激活之间的相互作用影响小鼠急性胰腺炎的严重程度</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770042</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32529941/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Early dysbiosis of the gut microbiota is associated with the severity of acute pancreatitis (AP), although the underlying mechanism is unclear. Here, we investigated the role of crosstalk between NLRP3 and the gut microbiota in the development of AP utilizing gut microbiota deficient mice, as well as NLRP3 knockout (KO) mouse models. Pancreatic damage and systemic inflammation were improved in antibiotic-treated (Abx) and germ-free (GF) mice, accompanied by weakened activity of the intestinal NLRP3 inflammasome. Interestingly, fecal microbiota transplantation (FMT) reactivated the intestinal NLRP3 inflammasome and exacerbated the disease in Abx and GF mice. Although the gut barrier in GF and Abx mice was disrupted, gut microbiota deficiency ameliorated the severity of AP, probably due to the reduction in bacterial translocation from the gut to the pancreas. The composition of the gut microbiota was significantly different between NLRP3 KO mice and wild-type (WT) mice at baseline, and there were alterations in response to the induction of AP. While a dramatic shift in the gut microbiota with overgrowth of Escherichia-Shigella was observed in WT mice suffering from AP, there was no significant change in NLRP3 KO mice with or without AP, suggesting that NLRP3 deficiency counteracts AP-induced microbial disturbance. With a strengthened gut barrier and decreased systemic inflammation, NLRP3 KO mice showed less severe AP, as revealed by reduced pancreatic neutrophilic infiltration and necrosis. Taken together, these results identified the bidirectional modulation between the gut microbiota and NLRP3 in the progression of AP, which suggests the interplay of the host and microbiome during AP.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群早期失调与急性胰腺炎（AP）的严重程度有关，尽管其潜在机制尚不清楚。在这里，我们调查了NLRP3和肠道菌群之间的串扰在利用肠道菌群不足的小鼠以及NLRP3基因敲除（KO）小鼠模型开发AP的过程中的作用。抗生素治疗（Abx）和无菌细菌（GF）小鼠的胰腺损伤和全身炎症得到改善，同时肠道NLRP3炎性小体的活性减弱。有趣的是，粪便微生物群移植（FMT）重新激活了肠道NLRP3炎性小体，并加剧了Abx和GF小鼠的疾病。尽管GF和Abx小鼠的肠屏障被破坏，但肠道菌群缺乏改善了AP的严重程度，这可能是由于细菌从肠到胰腺的转运减少所致。NLRP3KO小鼠和野生型（WT）小鼠之间的肠道菌群组成在基线时显着不同，并且对AP的诱导反应有所改变。尽管在患有AP的WT小鼠中观察到肠道菌群随埃希氏菌-志贺氏菌过度生长而发生了显着变化，但有或没有AP的NLRP3KO小鼠均无显着变化，这表明NLRP3缺乏可以抵消AP引起的微生物干扰。通过增强的肠道屏障和减少的全身炎症，NLRP3KO小鼠表现出较轻的AP，如胰腺中性粒细胞浸润和坏死的减少所显示。两者合计，这些结果确定了肠道菌群与NLRP3之间在AP进程中的双向调节，这提示了AP期间宿主与微生物组之间的相互作用。</p>

<h2>Pubmed_ID: 32522072</h2>

<h3>Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model</h3>

<h3>鼠李糖乳杆菌益生菌可预防鼠哮喘模型中的气道功能恶化并增强肠道微生物组的适应力</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766345</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32522072/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Allergic asthma is a highly prevalent inflammatory disease of the lower airways, clinically characterized by airway hyperreactivity and deterioration of airway function. Immunomodulatory probiotic bacteria are increasingly being explored to prevent asthma development, alone or in combination with other treatments. In this study, wild-type and recombinant probiotic Lactobacillus rhamnosus GR-1 were tested as preventive treatment of experimental allergic asthma in mice. Recombinant L. rhamnosus GR-1 was designed to produce the major birch pollen allergen Bet v 1, to promote allergen-specific immunomodulation. Administration of wild-type and recombinant L. rhamnosus GR-1 prevented the development of airway hyperreactivity. Recombinant L. rhamnosus GR-1 also prevented elevation of airway total cell counts, lymphocyte counts and lung IL-1β levels, while wild-type L. rhamnosus GR-1 inhibited airway eosinophilia. Of note, a shift in gut microbiome composition was observed after asthma development, which correlated with the severity of airway inflammation and airway hyperreactivity. In the groups that received L. rhamnosus GR-1, this asthma-associated shift in gut microbiome composition was not observed, indicating microbiome-modulating effects of this probiotic. These data demonstrate that L. rhamnosus GR-1 can prevent airway function deterioration in allergic asthma. Bet v 1 expression by L. rhamnosus GR-1 further contributed to lower airway inflammation, although not solely through the expected reduction in T helper 2-associated responses, suggesting involvement of additional mechanisms. The beneficial effects of L. rhamnosus GR-1 correlate with increased gut microbiome resilience, which in turn is linked to protection of airway function, and thus further adds support to the existence of a gut-lung axis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 过敏性哮喘是下呼吸道的高度流行的炎症性疾病，临床上以气道反应过度和气道功能恶化为特征。越来越多地探索免疫调节性益生菌单独或与其他疗法联合使用以预防哮喘的发展。在这项研究中，测试了野生型和重组益生菌鼠李糖乳杆菌GR-1作为小鼠实验性过敏性哮喘的预防性治疗。重组鼠李糖乳杆菌GR-1被设计为产生主要的桦树花粉变应原Betv1，以促进变应原特异性免疫调节。野生型和重组鼠李糖乳杆菌GR-1的使用可防止气道高反应性的发展。重组鼠李糖乳杆菌GR-1还阻止了气道总细胞计数，淋巴细胞计数和肺IL-1β水平的升高，而野生型鼠李糖乳杆菌GR-1抑制了气道嗜酸性粒细胞增多。值得注意的是，哮喘发生后肠道微生物组组成发生了变化，这与气道炎症和气道高反应性的严重程度相关。在接受鼠李糖乳杆菌GR-1的组中，未观察到与哮喘相关的肠道微生物组组成发生变化，表明该益生菌具有微生物组调节作用。这些数据表明，鼠李糖乳杆菌GR-1可以预防过敏性哮喘中的气道功能恶化。鼠李糖乳杆菌GR-1的Betv1表达进一步促进了气道炎症的降低，尽管这不仅是由于预期的与T辅助2相关的反应减少所致，还暗示了其他机制的参与。鼠李糖乳杆菌GR-1的有益作用与肠道微生物组的适应能力增强有关，而肠道微生物组的适应性又与保护气道功能有关，因此进一步增加了对肠肺轴的支持。</p>

<h2>Pubmed_ID: 32515657</h2>

<h3>Human resident gut microbe Bacteroides thetaiotaomicron regulates colonic neuronal innervation and neurogenic function</h3>

<h3>人体常驻肠道微生物拟杆菌（Theactotaides thetaiotaomicron）调节结肠神经元神经支配和神经源性功能</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766936</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32515657/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background and aims: As the importance of gut-brain interactions increases, understanding how specific gut microbes interact with the enteric nervous system (ENS), which is the first point of neuronal exposure becomes critical. Our aim was to understand how the dominant human gut bacterium Bacteroides thetaiotaomicron (Bt) regulates anatomical and functional characteristics of the ENS. Methods: Neuronal cell populations, as well as enteroendocrine cells, were assessed in proximal colonic sections using fluorescent immunohistochemistry in specific pathogen-free (SPF), germ-free (GF) and Bt conventionalized-germ-free mice (Bt-CONV). RNA expression of tight junction proteins and toll-like receptors (TLR) were measured using qPCR. Colonic motility was analyzed using in vitro colonic manometry. Results: Decreased neuronal and vagal afferent innervation observed in GF mice was normalized by Bt-CONV with increased neuronal staining in mucosa and myenteric plexus. Bt-CONV also restored expression of nitric oxide synthase expressing inhibitory neurons and of choline acetyltransferase and substance P expressing excitatory motor neurons comparable to those of SPF mice. Neurite outgrowth and glial cells were upregulated by Bt-CONV. RNA expression of tight junction protein claudin 3 was downregulated while TLR2 was upregulated by Bt-CONV. The enteroendocrine cell subtypes L-cells and enterochromaffin cells were reduced in GF mice, with Bt-CONV restoring L-cell numbers. Motility as measured by colonic migrating motor complexes (CMMCs) increased in GF and Bt-CONV. Conclusion: Bt, common gut bacteria, is critical in regulating enteric neuronal and enteroendocrine cell populations, and neurogenic colonic activity. This highlights the potential use of this resident gut bacteria for maintaining healthy gut function.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景和目的：随着肠脑相互作用的重要性不断提高，了解特定肠道微生物如何与肠道神经系统（ENS）相互作用（肠道神经系统暴露的第一步）变得至关重要。我们的目的是了解人类的肠道细菌细菌拟杆菌（Bteroidesthetaiotaomicron）（Bt）如何调节ENS的解剖学和功能特征。方法：在特定的无病原体（SPF），无细菌（GF）和Bt常规无病小鼠（Bt-CONV）中，使用荧光免疫组织化学方法在近端结肠切片中评估神经元细胞和肠内分泌细胞。使用qPCR测量紧密连接蛋白和toll样受体（TLR）的RNA表达。使用体外结肠测压法分析结肠运动性。结果：通过Bt-CONV可以使GF小鼠神经元和迷走神经传入神经减少，并使粘膜和肌间神经丛的神经元染色增加。与SPF小鼠相比，Bt-CONV还恢复了表达一氧化氮合酶的抑制性神经元以及表达胆碱乙酰转移酶和P物质的兴奋性运动神经元的表达。Bt-CONV上调了神经突的生长和神经胶质细胞。Bt-CONV下调紧密连接蛋白claudin3的RNA表达，而TLR2上调。GF小鼠的肠内分泌细胞亚型L细胞和嗜铬细胞减少，Bt-CONV恢复L细胞数量。通过结肠迁移运动复合物（CMMC）测得的运动能力在GF和Bt-CONV中增加。结论：Bt是常见的肠道细菌，在调节肠道神经元和肠内分泌细胞的数量以及神经原性结肠活性中至关重要。这突出了这种常驻肠道细菌在维持健康肠道功能方面的潜在用途。</p>

<h2>Pubmed_ID: 32507008</h2>

<h3>Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus</h3>

<h3>肠道菌群的改变与系统性红斑狼疮的细胞因子调节异常和糖皮质激素治疗有关</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768644</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32507008/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: A growing corpus of evidence implicates the involvement of the commensal microbiota and immune cytokines in the initiation and progression of systemic lupus erythematosus (SLE). Glucocorticoids have been widely used in the treatment of SLE patients, however, glucocorticoid treatment carries a higher risk of other diseases. Using the 16S rRNA technique, we investigated the differences between the gut microbiota associated with the immune cytokines of SLE and relevant glucocorticoid treatment in a female cohort of 20 healthy control subjects (HC), 17 subjects with SLE (SLE-G), and 20 SLE patients having undergone glucocorticoid treatment (SLE+G). We observed that the diversity and structure of the microbial community in SLE+G patients were significantly changed compared to that of SLE-G patients, whereas the gut microbial community of the SLE+G group showed a similarity with the HC group, which implicate that the shift in the gut microbiome could represent a return to homeostasis. Furthermore, the up-regulations of immune cytokines in SLE-G were identified as closely related to gut dysbiosis, which indicates that the overrepresented genera in SLE patients may play roles in regulating expression level of these immune cytokines. This associated analysis of gut microbiota, glucocorticoid therapy, and immune factors might provide novel and insightful clues revealing the pathogenesis of SLE patients.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明共生微生物和免疫细胞因子参与系统性红斑狼疮（SLE）的发生和发展。糖皮质激素已广泛用于SLE患者的治疗中，但是，糖皮质激素治疗具有其他疾病的较高风险。我们使用16SrRNA技术，在20名健康对照受试者（HC），17例SLE（SLE-G）和20名女性队列中研究了与SLE免疫细胞因子相关的肠道菌群和相关糖皮质激素治疗之间的差异接受糖皮质激素治疗（SLE+G）的SLE患者。我们观察到，与SLE-G患者相比，SLE+G患者的微生物群落的多样性和结构发生了显着变化，而SLE+G组的肠道微生物群落与HC组相似，这表明肠道微生物组的转变可能意味着体内稳态的恢复。此外，SLE-G中免疫细胞因子的上调与肠道营养不良密切相关，这表明SLE患者中过高的属可能在调节这些免疫细胞因子的表达水平中发挥作用。肠道微生物群，糖皮质激素治疗和免疫因子的相关分析可能会提供新颖而有见地的线索，揭示SLE患者的发病机理。</p>

<h2>Pubmed_ID: 32501768</h2>

<h3>Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect</h3>

<h3>肌萎缩性侧索硬化症和肠道菌群朝着确定因果关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1767464</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32501768/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The intestinal microbiota may be involved, through metabolic gut-brain interactions, in a variety of neurological conditions. In this addendum, we summarize the findings of our recent study investigating the potentially modulatory influence of the microbiome in a transgenic ALS mouse model, and the possible application to human disease. We found that transgenic mice show evidence of dysbiosis, even at the pre-symptomatic stage, and have a more severe disease course under germ-free conditions or after receiving broad-spectrum antibiotics. We demonstrated that Akkermansia muciniphila ameliorated the disease in mice and that this may be due to the production of nicotinamide. We then conducted a preliminary study in human ALS and identified functionally similar alterations within the metagenome. Furthermore, we found that patients with ALS had lower systemic and CSF levels of nicotinamide, suggesting that the changes observed in the mouse model may be relevant to human disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在各种神经系统疾病中，肠道微生物区可能通过代谢性肠脑相互作用而参与。在此附录中，我们总结了我们最近的研究结果，该研究调查了微生物组在转基因ALS小鼠模型中的潜在调节作用，以及对人类疾病的可能应用。我们发现，转基因小鼠即使在有症状的前期也显示出营养不良的迹象，并且在无菌条件下或接受广谱抗生素治疗后病情更严重。我们证明了Akkermansiamuciniphila改善了小鼠的疾病，这可能是由于烟酰胺的产生。然后，我们对人ALS进行了初步研究，并确定了基因组中功能相似的改变。此外，我们发现ALS患者的烟酰胺的全身和脑脊液水平较低，这表明在小鼠模型中观察到的变化可能与人类疾病有关。</p>

<h2>Pubmed_ID: 32453977</h2>

<h3>Indonesian children fecal microbiome from birth until weaning was different from microbiomes of their mothers</h3>

<h3>印尼儿童从出生到断奶的粪便微生物组与母亲的微生物组不同</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1761240</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32453977/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Gastrointestinal (GI) microbiota play an important role in human health and wellbeing and the first wave of gut microbes arrives mostly through vertical transmission from mother to child. This study has undertaken to understand the microbiota profile of healthy Southeast Asian mother-infant pairs. Here, we examined the fecal, vaginal and breast milk microbiota of Indonesian mothers and the fecal microbiota of their children from less than 1 month to 48 months old. To determine the immune status of children and the effect of diet at different ages, we examined the level of cytokines, bile acids in the fecal water and weaning food frequency. The fecal microbiota of the children before weaning contained mainly Bacteroides and Bifidobacterium, which presented at low abundance in the samples of mothers. After weaning, the fecal microbiome of children was mainly of the Prevotella type, with decreasing levels of Bifidobacterium, thus becoming more like the fecal microbiome of the mother. The abundance of infant fecal commensals generally correlated inversely with potential pathogens before weaning. The fecal Bifidobacterium in children correlated inversely with the consumption of complex carbohydrates and fruits after weaning. The specific cytokines related to the proliferation and maturation of immunity were found to increase after weaning. A decreasing level of primary bile acids and an increase of secondary bile acids were observed after weaning. This study highlights the change in the GI microbiota of infants to adult-type microbiota after weaning and identifies diet as a major contributing factor.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 胃肠道（GI）菌群在人类健康和福祉中起着重要作用，而肠道微生物的第一波潮主要通过母婴之间的垂直传播而到达。这项研究旨在了解健康的东南亚母婴对的微生物群特征。在这里，我们检查了印尼母亲的粪便，阴道和母乳菌群以及其小于1个月至48个月大的孩子的粪便菌群。为了确定儿童的免疫状态和不同年龄饮食的影响，我们检查了粪便水中的细胞因子，胆汁酸水平和断奶食物的频率。断奶前儿童的粪便微生物群主要含有拟杆菌和双歧杆菌，它们在母亲的样品中含量较低。断奶后，儿童的粪便微生物组主要是普勒沃氏菌类型，双歧杆菌水平降低，因此变得更像母亲的粪便微生物组。断奶前婴儿粪便的丰度通常与潜在病原体呈负相关。断奶后儿童粪便中的双歧杆菌与复杂碳水化合物和水果的摄入量成反比。断奶后发现与免疫增殖和成熟相关的特定细胞因子增加。断奶后观察到伯胆汁酸水平降低而仲胆汁酸水平升高。这项研究突出了断奶后婴儿的胃肠道菌群向成年型菌群的变化，并确定饮食是主要的促成因素。</p>

<h2>Pubmed_ID: 32453670</h2>

<h3>Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics</h3>

<h3>肠道微生物群修饰在结直肠癌治疗中的治疗方法-粪便微生物群移植，益生元，益生菌和合生元</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1764309</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32453670/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The link between gut microbiota and the development of colorectal cancer has been investigated. An imbalance in the gut microbiota promotes the progress of colorectal carcinogenesis via multiple mechanisms, including inflammation, activation of carcinogens, and tumorigenic pathways as well as damaging host DNA. Several therapeutic methods are available with which to alter the composition and the activity of gut microbiota, such as administration of prebiotics, probiotics, and synbiotics; these can confer various benefits for colorectal cancer patients. Nowadays, fecal microbiota transplantation is the most modern way of modulating the gut microbiota. Even though data regarding fecal microbiota transplantation in colorectal cancer patients are still rather limited, it has been approved as a clinical method of treatment-recurrent Clostridium difficile infection, which may also occur in these patients. The major benefits of fecal microbiota transplantation include modulation of immunotherapy efficacy, amelioration of bile acid metabolism, and restoration of intestinal microbial diversity. Nonetheless, more studies are needed to assess the long-term effects of fecal microbiota transplantation. In this review, the impact of gut microbiota on the efficiency of anti-cancer therapy and colorectal cancer patients' overall survival is also discussed.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群与结直肠癌的发展之间的联系已得到研究。肠道菌群失衡可通过多种机制促进大肠癌发生发展，包括炎症，致癌物激活和致瘤途径以及破坏宿主DNA。有几种治疗方法可用来改变肠道菌群的组成和活性，例如施用益生元，益生菌和合生元。这些可以为结直肠癌患者带来各种益处。如今，粪便微生物群移植是调节肠道微生物群的最现代方法。尽管关于结直肠癌患者粪便微生物群移植的数据仍然相当有限，但已被批准为治疗复发性艰难梭菌感染的临床方法，这些患者中也可能发生这种情况。粪便微生物群移植的主要好处包括调节免疫疗法的功效，改善胆汁酸的代谢以及恢复肠道微生物的多样性。尽管如此，需要更多的研究来评估粪便微生物群移植的长期效果。在这篇综述中，还讨论了肠道菌群对抗癌治疗效率和大肠癌患者总体生存的影响。</p>

<h2>Pubmed_ID: 32432992</h2>

<h3>An ethical investigation into the microbiome: the intersection of agriculture, genetics, and the obesity epidemic</h3>

<h3>微生物组的伦理调查：农业，遗传学和肥胖病流行的交集</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1760712</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32432992/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: There is growing evidence of the interconnectivity between animals, humans, and the environment, which has manifested in the One Health perspective that takes all three into account for a more comprehensive vision of health. Over the past century, agriculture has become increasingly industrialized with a particular rise in the amount of livestock raised and meat produced. In order to fulfill such market demands, livestock farmers and agricultural corporations have artificially selected for and bred their cash animals to be more and more metabolically efficient via genetic and human-driven means. However, by selecting for more metabolically efficient animals, we may have inadvertently been selecting for obesogenic gut microbiota. This is further compounded by the potential obesogenic and microbiome-altering role antibiotics play in livestock. Evidence suggests that there is the potential for interspecies gut microbe transmissibility. It is notable that there has been a concurrent multispecies obesity epidemic across the same timeframe, which raises questions about potential connections between these epidemics. If it is the case that humans have inadvertently influenced their own obesity epidemic via the artificial selection of and antibiotic administration to livestock, then this holds significant ethical implications. This analysis considers current meat consumption trends, the impacts of livestock on climate change, and animal ethics. The paper concludes that due to the potential significant impact yet tenuous nature of the evidence on this subject stemming from research silos, there is a definitive ethical impetus for researchers to bridge these silos to better understand the true nature of the issue. This case is emblematic of an overarching ethics-driven need for deeper collaboration between isolated but related research disciplines to better characterize issues of public health relevance. It also raises concerns regarding inherent value-driven strife that may arise between competing One Health domains.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明动物，人与环境之间的相互联系，这一点在“一个健康”的观点中得到了体现，该观点将这三个方面都纳入了对健康的更全面了解。在过去的一个世纪中，农业已变得越来越工业化，牲畜和肉类的产量特别增加。为了满足这样的市场需求，畜牧业者和农业公司通过遗传和人类驱动手段人为地选择并繁育了他们的现金动物，使其代谢效率越来越高。但是，通过选择代谢效率更高的动物，我们可能会无意中选择了致肥胖的肠道菌群。抗生素在牲畜中发挥潜在的致肥胖作用和改变微生物的作用，进一步加剧了这种情况。有证据表明，种间肠道微生物具有潜在的传播能力。值得注意的是，在同一时间段内并存的多物种肥胖病流行，这引发了人们对这些流行病之间潜在联系的质疑。如果情况是人类通过对牲畜的人工选择和抗生素施用而无意中影响了自身的肥胖病流行，那么这将具有重大的伦理意义。该分析考虑了当前的肉类消费趋势，牲畜对气候变化的影响以及动物伦理。该论文的结论是，由于研究孤岛对这一问题的潜在重大影响和微不足道的性质，研究人员存在确定的道德动力，可以桥接这些孤岛以更好地理解问题的真实性质。该案例象征着以道德为主导的总体需求，即需要在孤立但相关的研究学科之间进行更深层次的合作，以更好地描述与公共卫生相关的问题。这也引发了人们对相互竞争的“一站式”服务域之间可能发生的内在价值驱动冲突的担忧。</p>

<h2>Pubmed_ID: 32403964</h2>

<h3>The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome</h3>

<h3>益生菌干酪乳杆菌LC-XCAL™可改善饮食诱发的肥胖小鼠模型的代谢健康，而无需改变微生物组</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1747330</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32403964/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Chronic low-grade inflammation associated with obesity may be a target for improvement of metabolic health. Some exopolysaccharide (EPS)-producing bacteria have been shown to have anti-inflammatory effects in gastrointestinal inflammatory conditions. However, evidence for the role of EPS-producing probiotics in the management of obesity and associated conditions is scarce and the role of the microbiota is unclear. In this study, two probiotic candidates were screened for their effects on metabolic health using the diet-induced obesity (DIO) mouse model. Mice fed a high-fat diet supplemented with the anti-inflammatory, EPS-producing strain L. casei LC-XCAL™ showed significantly reduced hepatic triglycerides, hepatic total cholesterol, and fat pad weight compared to those fed a high-fat diet alone, likely as a result of reduced energy absorption from food. 16-S rRNA amplicon analysis of the fecal microbiota of these mice indicated that the altered metabolic phenotype as a result of the L. casei LC-XCAL strain administration was not associated with an overall change in the composition or inferred functional capacity of the fecal microbiota despite some abundance changes in individual taxa and functions. These findings provide evidence that specific microbial strategies can improve metabolic health independent of the microbiome and reinforce the importance of carefully selecting the most appropriate strain for specific indications by thorough screening programmes.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 与肥胖有关的慢性低度炎症可能是改善代谢健康的目标。已经显示一些产生胞外多糖（EPS）的细菌在胃肠炎性疾病中具有抗炎作用。但是，关于产生EPS的益生菌在肥胖症和相关疾病管理中的作用的证据很少，微生物群的作用尚不清楚。在这项研究中，使用饮食诱导肥胖症（DIO）小鼠模型筛选了两个益生菌候选物对代谢健康的影响。与仅饲喂高脂饮食的小鼠相比，饲喂高脂饮食并补充有抗炎，EPS的产乳杆菌L.caseiLC-XCAL™的小鼠显示出明显降低的肝甘油三酸酯，肝脏总胆固醇和脂肪垫的重量，可能是由于食物吸收能量减少所致。对这些小鼠粪便菌群的16-SrRNA扩增子分析表明，由于干酪乳杆菌LC-XCAL菌株给药而导致的代谢表型改变与粪便菌群的成分总体变化或推断的功能能力无关。尽管个别分类单元和功能发生了很多变化。这些发现提供了证据，表明特定的微生物策略可以独立于微生物组而改善代谢健康，并通过全面的筛查程序来加强针对特定适应症仔细选择最合适菌株的重要性。</p>

<h2>Pubmed_ID: 32200683</h2>

<h3>Probiotic-directed modulation of gut microbiota is basal microbiome dependent</h3>

<h3>益生菌指导的肠道菌群调控是基础微生物组依赖的</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1736974</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32200683/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: As an effective means to improve quality of life and prevent diseases, the demand for probiotics and related products has increased in recent years. However, it is still unclear whether a particular probiotic strain will have similar beneficial effects on healthy adults from different regions. In this study, the probiotic Lactobacillus casei Zhang (LCZ) was consumed by healthy adults from six different Asian regions and the changes in gut microbiota were compared using PacBio single molecule, real-time (SMRT) sequencing technology based on samples collected before, during and after consumption of LCZ. Our results reveal that the effect of LCZ consumption on individuals was closely related to the composition of that individual's basal gut microbiota. A Gut Microbiota Variability Index (GMVI) was proposed to quantitatively compare the effects of LCZ on human gut microecology. Subjects from Xinjiang and Singapore regions had the highest and lowest GMVI, respectively. In general, consumption of LCZ increased the relative abundance of certain beneficial bacteria such as Lactobacillus, Roseburia, Coprococcus and Eubacterium rectale, while it inhibited growth of certain harmful bacteria such as Blautia and Ralstonia pickettii. In addition, consumption of LCZ was responsible for the conversion of some participants from Prevotella copri/Faecalibacterium prausnitzii (PF) enterotype to Faecalibacterium prausnitzii/Bacteroides dorei (FB) enterotype and consistently increased the abundance of lactic acid bacteria in the gut. It also increased/enhanced phosphate metabolic modules, amino acid transport systems, and isoleucine biosynthesis, but conversely decreased lipopolysaccharide biosynthesis. These changes could have health benefits for healthy adults.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 作为改善生活质量和预防疾病的有效手段，近年来对益生菌和相关产品的需求在增加。然而，尚不清楚特定的益生菌菌株是否会对来自不同地区的健康成年人产生类似的有益作用。在这项研究中，来自六个亚洲地区的健康成年人食用了益生菌干酪乳杆菌（LCZ），并使用PacBio单分子实时（SMRT）测序技术，根据之前，期间和之后收集的样品，比较了肠道菌群的变化。消耗掉LCZ之后。我们的结果表明，食用LCZ对个体的影响与该个体的基础肠道菌群的组成密切相关。提出了肠道菌群变异指数（GMVI），以定量比较LCZ对人体肠道微生态的影响。新疆和新加坡地区的受试者的GMVI分别最高和最低。通常，食用LCZ会增加某些有益细菌（如乳酸杆菌，玫瑰菌，协球菌和直肠真细菌）的相对丰度，同时会抑制某些有害细菌（如蓝藻和拟南芥Ralstoniapickettii）的生长。此外，LCZ的消耗还导致一些参与者从普氏杆菌/普氏杆菌（PF）肠型转化为普氏杆菌/多形杆菌（FB）肠型，并不断增加肠道中乳酸菌的丰度。它也增加/增强了磷酸盐代谢模块，氨基酸转运系统和异亮氨酸的生物合成，但相反降低了脂多糖的生物合成。这些变化对健康的成年人可能具有健康益处。</p>

<h2>Pubmed_ID: 32129694</h2>

<h3>MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE</h3>

<h3>肠道菌感染和细菌性肠病的微生物学研究</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1725220</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32129694/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation that includes Crohn´s disease (CD) and ulcerative colitis (UC). Although the etiology is still unknown, some specific factors have been directly related to IBD, including genetic factors, abnormal intestinal immunity, and/or gut microbiota modifications. Recent findings highlight the primary role of the gut microbiota closely associated with a persistent inappropriate inflammatory response. This gut environment of dysbiosis in a susceptible IBD host can increasingly worsen and lead to colonization and infection with some opportunistic pathogens, especially Clostridium difficile. C. difficile is an intestinal pathogen considered the main cause of antibiotic-associated diarrhea and colitis and an important complication of IBD, which can trigger or worsen an IBD flare. Recent findings have highlighted the loss of bacterial cooperation in the gut ecosystem, as well as the pronounced intestinal dysbiosis, in patients suffering from IBD and concomitant C. difficile infection (CDI). The results of intestinal microbiota studies are still limited and often difficult to compare because of the variety of disease conditions. However, these data provide important clues regarding the main modifications and interrelations in the complicated gut ecosystem to better understand both diseases and to take advantage of the development of new therapeutic strategies. In this review, we analyze in depth the gut microbiota changes associated with both forms of IBD and CDI and their similarity with the dysbiosis that occurs in CDI. We also discuss the metabolic pathways that favor the proliferation or decrease in several important taxa directly related to the disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 炎症性肠病（IBD）的特征在于慢性肠道炎症，包括克罗恩病（CD）和溃疡性结肠炎（UC）。尽管病因尚不明确，但某些特定因素已与IBD直接相关，包括遗传因素，肠道免疫异常和/或肠道菌群改变。最近的发现强调了肠道微生物群与持续的不适当的炎症反应密切相关的主要作用。在易感的IBD宿主中，这种营养不良的肠道环境可能会日益恶化，并导致定居和感染某些机会性病原体，尤其是艰难梭菌。艰难梭菌是一种肠道病原体，被认为是与抗生素有关的腹泻和结肠炎的主要原因，也是IBD的重要并发症，可引起或加剧IBD发作。最近的发现凸显了患有IBD和伴随艰难梭菌感染（CDI）的患者肠道生态系统中细菌协作的丧失，以及明显的肠道营养不良。由于疾病状况的多样性，肠道菌群研究的结果仍然有限，并且通常难以比较。但是，这些数据提供了有关复杂肠道生态系统中主要修饰和相互关系的重要线索，以更好地了解两种疾病并利用新治疗策略的发展。在这篇综述中，我们深入分析了与IBD和CDI两种形式相关的肠道菌群变化，以及它们与CDI中发生的营养不良的相似性。我们还讨论了有利于与疾病直接相关的几种重要分类单元的增殖或减少的代谢途径。</p>

<h2>Pubmed_ID: 31996393</h2>

<h3>Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring</h3>

<h3>产妇低剂量的母体低剂量阿斯巴甜和甜菊糖摄入可改变大鼠大坝及其后代的代谢，肠道菌群和中脑边缘奖励系统</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2018-317505</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31996393/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Oct</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: We examined the impact of maternal low-dose aspartame and stevia consumption on adiposity, glucose tolerance, gut microbiota and mesolimbic pathway in obese dams and their offspring. Design: Following obesity induction, female Sprague-Dawley rats were allocated during pregnancy and lactation to: (1) high fat/sucrose diet (HFS) +water (obese-WTR); (2) HFS +aspartame (obese-APM; 5-7 mg/kg/day); (3) HFS +stevia (obese-STV; 2-3 mg/kg/day). Offspring were weaned onto control diet and water and followed until 18 weeks. Gut microbiota and metabolic outcomes were measured in dams and offspring. Cecal matter from offspring at weaning was used for faecal microbiota transplant (FMT) into germ-free (GF) mice. Results: Maternal APM and STV intake with a HFS diet increased body fat in offspring at weaning and body weight long-term with APM. Maternal APM/HFS consumption impaired glucose tolerance in male offspring at age 8 weeks and both APM and STV altered faecal microbiota in dams and offspring. Maternal obesity/HFS diet affected offspring adiposity and glucose tolerance more so than maternal LCS consumption at age 12 and 18 weeks. APM and STV altered expression of genes in the mesolimbic reward system that may promote consumption of a palatable diet. GF mice receiving an FMT from obese-APM and obese-STV offspring had greater weight gain and body fat and impaired glucose tolerance compared with obese-WTR. Conclusion: Maternal low-calorie sweetener consumption alongside HFS may disrupt weight regulation, glucose control and gut microbiota in dams and their offspring most notably in early life despite no direct low-calorie sweetener consumption by offspring.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：我们研究了孕妇低剂量阿斯巴甜和甜菊糖摄入对肥胖大坝及其后代肥胖，葡萄糖耐量，肠道菌群和中脑边缘途径的影响。设计：诱导肥胖后，将雌性Sprague-Dawley大鼠在妊娠和哺乳期分配给：（1）高脂/蔗糖饮食（HFS）+水（肥胖-WTR）；（2）HFS+阿斯巴甜（肥胖-APM;5-7mg/kg/天）;（3）HFS+甜叶菊（肥胖-STV；2-3mg/kg/天）。将后代断奶至对照饮食和水中，并随访至18周。在大坝和后代中测量肠道菌群和代谢结果。断奶后代的盲肠被用于粪便菌群移植（FMT）进入无菌（GF）小鼠。结果：HFS饮食的孕妇APM和STV摄入增加了断奶后代的体内脂肪，而长期使用APM则增加了体重。母体摄入APM/HFS会损害8周龄雄性后代的葡萄糖耐量，并且APM和STV都会改变大坝和后代的粪便微生物群。母体肥胖/HFS饮食对子代肥胖和葡萄糖耐量的影响大于12和18周龄母体LCS摄入量。APM和STV改变了中边缘边缘奖励系统中基因的表达，这可能促进食用可口的饮食。与肥胖的WTR相比，从肥胖的APM和肥胖的STV后代接受FMT的GF小鼠体重增加，体脂增加，糖耐量降低。结论：母体低热量甜味剂与HFS一起食用可能会破坏大坝及其后代的体重调节，葡萄糖控制和肠道菌群，尽管后代没有直接消耗低热量甜味剂。</p>

<h2>Pubmed_ID: 31983316</h2>

<h3>Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity</h3>

<h3>饮食限制会增加保护性肠道细菌，以挽救甲氨蝶呤致死的肠道毒性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1714401</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31983316/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Methotrexate (MTX) is a typical chemotherapeutic drug that is widely used in the treatment of various malignant diseases as well as autoimmune diseases, with gastrointestinal toxicity being its most prominent complication which could have a significant effect on the prognosis of patients. Yet effective ways to alleviate such complications remains to be explored. Here we show that 30% dietary restriction (DR) for 2 weeks dramatically increased the survival rate of 2-month-old female mice after lethal-dose MTX exposure. DR significantly reduced intestinal inflammation, preserved the number of basal crypt PCNA-positive cells, and protected the function of intestinal stem cells (ISCs) after MTX treatment. Furthermore, ablating intestinal microbiota by broad-spectrum antibiotics completely eliminated the protective effect achieved by DR. 16S rRNA gene deep-sequencing analysis revealed that short-term DR significantly increased the Lactobacillus genus, with Lactobacillus rhamnosus GG gavage partially mimicking the rescue effect of DR on the intestines of ad libitum fed mice exposed to lethal-dose MTX. Together, the current study reveals that DR could be a highly effective way to alleviate the lethal injury in the intestine after high-dose MTX treatment, which is functionally mediated by increasing the protective intestinal microbiota taxa in mice. Keywords: Dietary restriction, Methotrexate, Gut microbiota, Intestinal stem cells, intestinal toxicity.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 甲氨蝶呤（MTX）是一种典型的化学治疗药物，广泛用于治疗各种恶性疾病以及自身免疫性疾病，其中胃肠道毒性是最主要的并发症，可能对患者的预后产生重大影响。然而，减轻这种并发症的有效方法仍有待探索。在这里，我们显示了30％的饮食限制（DR）2周可显着提高致死剂量MTX暴露后2个月大的雌性小鼠的存活率。DR显着减少肠道炎症，保留了基底隐窝PCNA阳性细胞的数量，并在MTX治疗后保护了肠道干细胞（ISC）的功能。此外，用广谱抗生素消融肠道菌群完全消除了DR的保护作用。16SrRNA基因深度测序分析显示，短期DR显着增加了乳杆菌属，鼠李糖乳杆菌GG灌胃部分模拟了DR对暴露于致死剂量MTX的随意喂养小鼠肠道的拯救作用。总之，当前的研究表明，DR可能是减轻大剂量MTX治疗后肠道致死性损伤的一种有效方法，该作用在功能上是通过增加小鼠的保护性肠道菌群来介导的。关键词：饮食限制，甲氨蝶呤，肠道菌群，肠干细胞，肠毒性。</p>

<h2>Pubmed_ID: 31983281</h2>

<h3>Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit</h3>

<h3>麦麸来源的益生元补充剂对胃肠道转运，肠道菌群和代谢健康的影响：在肠道缓慢转运的健康成年人中的随机对照试验</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1704141</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31983281/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Acute intake of the wheat bran extract Arabinoxylan-Oligosaccharide (AXOS) modulates the gut microbiota, improves stool characteristics and postprandial glycemia in healthy humans. Yet, little is known on how long-term AXOS intake influences gastrointestinal (GI) functioning, gut microbiota, and metabolic health. In this randomized, placebo-controlled, double-blind study, we evaluated the effects of AXOS intake on GI function and metabolic health in adults with slow GI transit without constipation. Forty-eight normoglycemic adults were included with whole-gut transit time (WGTT) of >35 h receiving either 15 g/day AXOS or placebo (maltodextrin) for 12-wks. The primary outcome was WGTT, and secondary outcomes included stool parameters, gut permeability, short-chain fatty acids (SCFA), microbiota composition, energy expenditure, substrate oxidation, glucose, insulin, lipids, gut hormones, and adipose tissue (AT) function. WGTT was unchanged, but stool consistency softened after AXOS. 12-wks of AXOS intake significantly changed the microbiota by increasing Bifidobacterium and decreasing microbial alpha-diversity. With a good classification accuracy, overall microbiota composition classified responders with decreased WGTT after AXOS. The incretin hormone Glucagon-like protein 1 was reduced after AXOS compared to placebo. Energy expenditure, plasma metabolites, AT parameters, SCFA, and gut permeability were unchanged. In conclusion, intake of wheat bran extract increases fecal Bifidobacterium and softens stool consistency without major effects on energy metabolism in healthy humans with a slow GI transit. We show that overall gut microbiota classified responders with decreased WGTT after AXOS highlighting that GI transit and change thereof were associated with gut microbiota independent of Bifidobacterium. NCT02491125.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 麦麸提取物阿拉伯木聚糖寡糖（AXOS）的急性摄入可调节健康人的肠道菌群，改善粪便特性和餐后血糖。然而，关于AXOS的长期摄入如何影响胃肠（GI）功能，肠道菌群和代谢健康还知之甚少。在这项随机，安慰剂对照，双盲研究中，我们评估了AXOS摄入量对没有便秘的缓慢GI转运的成年人的GI功能和代谢健康的影响。包括48名正常血糖成人，其全肠运输时间（WGTT）>35小时，接受15g/天的AXOS或安慰剂（麦芽糊精）治疗12周。主要结果是WGTT，次要结果包括粪便参数，肠道通透性，短链脂肪酸（SCFA），微生物群组成，能量消耗，底物氧化，葡萄糖，胰岛素，脂质，肠道激素和脂肪组织（AT）功能。WGTT不变，但AXOS后大便稠度减弱。摄入12周的AXOS可通过增加双歧杆菌和减少微生物的α多样性来显着改变微生物群。凭借良好的分类准确性，总体微生物群组成对AXOS后WGTT降低的应答者进行了分类。与安慰剂相比，AXOS后肠降血糖素激素胰高血糖素样蛋白1减少。能量消耗，血浆代谢物，AT参数，SCFA和肠通透性均未改变。总之，摄入麦麸提取物可增加粪便中的双歧杆菌，并能软化粪便的稠度，而不会对胃肠道运输缓慢的健康人的能量代谢产生重大影响。我们显示了AXOS后WGTT下降的整体肠道菌群分类响应者，突出显示了胃肠道转运及其变化与独立于双歧杆菌的肠道菌群相关。NCT02491125。</p>

<h2>Pubmed_ID: 31942825</h2>

<h3>Systematic review of human gut resistome studies revealed variable definitions and approaches</h3>

<h3>对人体肠道抵抗组研究的系统评价揭示了可变的定义和方法</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1700755</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31942825/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: In this review, we highlight the variations of gut resistome studies, which may preclude comparisons and translational interpretations. Of 22 included studies, a range of 12 to 2000 antibiotic resistance (AR) genes were profiled. Overall, studies defined a healthy gut resistome as subjects who had not taken antibiotics in the last three to 12 months prior to sampling. In studies with de novo assembly, AR genes were identified based on variable nucleotide or amino acid sequence similarities. Different marker genes were used for defining resistance to a given antibiotic class. Validation of phenotypic resistance in the laboratory is frequently lacking. Cryptic resistance, collateral sensitivity and the interaction with repressors or promotors were not investigated. International consensus is needed for selecting marker genes to define resistance to a given antibiotic class in addition to uniformity in phenotypic validation and bioinformatics pipelines.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在这篇综述中，我们重点介绍了肠道抵抗组研究的各种变化，这些变化可能排除了比较和翻译解释的可能性。在22项纳入研究中，分析了12到2000种抗生素抗性（AR）基因。总体而言，研究将健康的肠道抵抗组定义为在采样前的最后3至12个月内未服用抗生素的受试者。在从头组装的研究中，AR基因是根据可变的核苷酸或氨基酸序列相似性鉴定的。使用不同的标记基因来定义对给定抗生素类别的抗性。经常缺乏实验室对表型耐药性的验证。未研究抗隐窝性，附带敏感性以及与阻遏物或启动子的相互作用。除了表型验证和生物信息学流程的一致性外，还需要国际共识来选择标记基因来定义对给定抗生素类别的抗性。</p>

<h2>Pubmed_ID: 31924126</h2>

<h3>Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis</h3>

<h3>重症患者肠道菌群谱，潜在生物标志物和败血症风险变量</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1707610</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31924126/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Critically ill patients are physiologically unstable and recent studies indicate that the intestinal microbiota could be involved in the health decline of such patients during ICU stays. This study aims to assess the intestinal microbiota in critically ill patients with and without sepsis and to determine its impact on outcome variables, such as medical complications, ICU stay time, and mortality. A multi-center study was conducted with a total of 250 peri-rectal swabs obtained from 155 patients upon admission and during ICU stays. Intestinal microbiota was assessed by sequencing the V3-V4 hypervariable regions of the 16S rRNA gene. Linear mixed models were used to integrate microbiota data with more than 40 clinical and demographic variables to detect covariates and minimize the effect of confounding factors. We found that the microbiota of ICU patients with sepsis has an increased abundance of microbes tightly associated with inflammation, such as Parabacteroides, Fusobacterium and Bilophila species. Female sex and aging would represent an increased risk for sepsis possibly because of some of their microbiota features. We also evidenced a remarkable loss of microbial diversity, during the ICU stay. Concomitantly, we detected that the abundance of pathogenic species, such as Enterococcus spp., was differentially increased in sepsis patients who died, indicating these species as potential biomarkers for monitoring during ICU stay. We concluded that particular intestinal microbiota signatures could predict sepsis development in ICU patients. We propose potential biomarkers for evaluation in the clinical management of ICU patients.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 重症患者的生理状况不稳定，最近的研究表明，在ICU住院期间，肠道菌群可能与此类患者的健康下降有关。这项研究旨在评估患有或不患有败血症的危重患者的肠道菌群，并确定其对结果变量的影响，例如医疗并发症，ICU停留时间和死亡率。一项多中心研究对入院时和重症监护病房住院期间从155例患者中获得的共250颗直肠周拭子进行了研究。通过对16SrRNA基因的V3-V4高变区进行测序来评估肠道菌群。线性混合模型用于将微生物群数据与40多个临床和人口统计学变量整合在一起，以检测协变量并最小化混杂因素的影响。我们发现，ICU脓毒症患者的微生物群具有与炎症紧密相关的大量微生物，如副细菌，梭菌和Bilophila菌种。性别和衰老可能由于某些微生物群特征而导致败血症的风险增加。在ICU停留期间，我们还证明了微生物多样性的显着丧失。同时，我们检测到死亡的败血症患者中病原菌种类（如肠球菌）的丰度有所增加，表明这些菌种可作为在ICU住院期间监测的潜在生物标记。我们得出的结论是，特定的肠道菌群特征可以预测ICU患者的败血症发展。我们提出潜在的生物标志物，以评估ICU患者的临床管理。</p>

<h2>Pubmed_ID: 31760871</h2>

<h3>Triclocarban exposure exaggerates colitis and colon tumorigenesis: roles of gut microbiota involved</h3>

<h3>三氯卡班暴露会加剧结肠炎和结肠肿瘤的发生：肠道菌群的作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1690364</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31760871/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Triclocarban (TCC) is a widely used antimicrobial ingredient in consumer products and is a ubiquitous contaminant in the environment. In 2016, the FDA removed TCC from over-the-counter handwashing products, but this compound is still approved for use in many other personal care products. A better understanding of its impact on human health could lead to significant impact for public health and regulatory policies. Here we show that exposure to low-dose TCC exaggerated the severity of colitis and exacerbated the development of colitis-associated colon tumorigenesis, via gut microbiota-dependent mechanisms. Exposure to TCC increased dextran sodium sulfate (DSS)- and interleukin 10 (IL-10) knockout-induced colitis, and exaggerated azoxymethane (AOM)/DSS-induced colon tumorigenesis in mice. Regarding the mechanisms, TCC exposure reduced the diversity and altered the composition of gut microbiota and failed to promote DSS-induced colitis in mice lacking the microbiota, supporting that the presence of the microbiota is critical for the pro-colitis effects of TCC. Together, these results support TCC could be a novel risk factor for colitis and colitis-associated colon cancer, and further regulatory policies on this compound could be needed.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 三氯卡班（TCC）是消费产品中广泛使用的抗菌成分，并且是环境中普遍存在的污染物。2016年，FDA从非处方洗手产品中删除了TCC，但该化合物仍被批准用于许多其他个人护理产品中。更好地了解其对人类健康的影响可能会对公共卫生和监管政策产生重大影响。在这里，我们显示，通过肠道菌群依赖性机制，低剂量TCC暴露会加剧结肠炎的严重性，并加剧结肠炎相关结肠肿瘤的发生。暴露于TCC会增加小鼠右旋糖酐硫酸钠（DSS）和白介素10（IL-10）敲除引起的结肠炎，并加剧乙氧基甲烷（AOM）/DSS引起的结肠肿瘤发生。关于机制，TCC暴露降低了缺乏微生物群的小鼠中肠道微生物群的多样性并改变了肠道微生物群的组成，并且未能促进DSS诱导的结肠炎，这表明微生物群的存在对于TCC的结肠炎前期效应至关重要。总之，这些结果支持TCC可能是结肠炎和与结肠炎相关的结肠癌的一种新型危险因素，因此可能需要对该化合物进一步的监管政策。</p>

<h2>Pubmed_ID: 31684806</h2>

<h3>Origins of human milk microbiota: new evidence and arising questions</h3>

<h3>人乳微生物群的起源：新证据和新出现的问题</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1667722</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31684806/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Human milk contains a diverse community of bacteria. The growing appreciation of commensal microbes and increasing availability of high-throughput technology has set the stage for a theory-driven approach to the study of milk microbiota, and translation of this knowledge to improve maternal and child health. We recently profiled the milk microbiota of healthy Canadian mothers and applied theory-driven causal modeling, finding that mode of breast milk feeding (nursing directly at the breast vs. pumping and feeding breast milk from a bottle) was significantly associated with milk microbiota composition. This observation could reflect an increased exposure to pumps and/or a decreased exposure to the infant mouth. Either way, it provides evidence for the retrograde mechanism of milk inoculation. Here, we discuss the implications of this research and related controversies, and raise new questions about the origins and function of milk bacteria.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 母乳含有多种多样的细菌。对共生微生物的日益了解以及高通量技术的日益普及，已经为理论驱动的方法研究牛奶微生物群和转化知识以改善母婴健康奠定了基础。我们最近对健康的加拿大母亲的牛奶菌群进行了分析，并应用了理论驱动的因果模型，发现母乳喂养方式（直接在母乳喂养与从瓶中泵送和喂养母乳）与微生物菌群组成显着相关。该观察结果可能反映出增加了对泵的暴露和/或减少了对婴儿口的暴露。无论哪种方式，它都为牛奶接种的逆行机制提供了证据。在这里，我们讨论了这项研究的意义和相关争议，并对乳细菌的起源和功能提出了新的问题。</p>

</body>
</html>

